Exclusions for E4_PCOS_BROAD

E4_PCOS_BROAD_EXCLUSIONS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C74, D35.2&, E22, E23, E24, E25, E27, Q96 Hospital discharge: ICD-9 — 2273\|253\|255\|6116\|2270\|194 Hospital discharge: ICD-8 — 2262\|253\|255\|258\|2260 Cause of death: ICD-10 — C74, D35.2&, E22, E23, E24, E25, E27, Q96 Cause of death: ICD-9 — 2273\|253\|255\|6116\|2270\|194 Cause of death: ICD-8 — 2262\|253\|255\|258\|2260 2 out of 7 registries used, show all original rules.	7495
4. Check minimum number of events None	7495
5. Include endpoints None	7495
6. Filter based on genotype QC (FinnGen only)	7495

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF6v3

NAME	E4_PCOS_BROAD_EXCLUSIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D352\|E22\|E23\|E24\|E25\|E27\|Q96\|C74\|E221
HD_ICD_9	2273\|253\|255\|6116\|2270\|194
HD_ICD_8	2262\|253\|255\|258\|2260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D352\|E22\|E23\|E24\|E25\|E27\|Q96\|C74\|E221
COD_ICD_9	2273\|253\|255\|6116\|2270\|194
COD_ICD_8	2262\|253\|255\|258\|2260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exclusions for E4_PCOS_BROAD based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7495	4453	3042
Unadjusted period prevalence (%)	1.45	1.52	1.34
Median age at first event (years)	45.17	40.31	52.28

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6697: Matched controls
66904

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

+∞

323.0

1519

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

323.0

579

G02CB01

ATC

bromocriptine; systemic

16.0

323.0

544

367

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

229.4

323.0

896

101

Kela drug reimbursment

Anterior pituitary hypofunction

603.2

323.0

940

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

2078.5

323.0

370

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

2967.7

323.0

567

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

179.3

323.0

1122

H03AA01

ATC

levothyroxine sodium; systemic

3.4

323.0

2259

8749

105

Kela drug reimbursment

Adrenal cortical hypofunction

1704.2

323.0

315

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

10.8

323.0

1181

1296

E22.1

ICD-10 Finland

Hyperprolactinaemia

1386.2

323.0

1245

E23.05

ICD-10 Finland

Lack of TSH

867.9

323.0

331

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

9.4

323.0

713

835

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

1861.1

323.0

373

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

1449.9

323.0

534

H02AB09

ATC

hydrocortisone; systemic

59.0

323.0

1883

440

N04BC06

ATC

cabergoline; oral (dopamine agonists)

162.1

323.0

496

H01AC01

ATC

somatropin; parenteral

73.2

309.9

355

102

Kela drug reimbursment

Diabetes insipidus

1401.2

276.6

268

E23.2

ICD-10 Finland

Diabetes insipidus

679.0

266.6

262

E23.03

ICD-10 Finland

Lack of ACTH

+∞

253.6

242

H02AA02

ATC

fludrocortisone; oral

36.2

246.4

321

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

2273.3

238.7

230

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

227.9

235.3

242

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

246.4

232.5

238

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

+∞

207.3

198

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

504.6

198.6

197

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

8.8

185.7

416

498

E27.0

ICD-10 Finland

Other adrenocortical overactivity

911.9

182.1

178

G02CB03

ATC

cabergoline; oral (prolactine inhibitors)

49.4

173.0

211

E23.06

ICD-10 Finland

Empty sella

+∞

160.0

153

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.5

156.8

829

2625

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

1583.5

155.7

151

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.7

153.7

472

882

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.9

142.6

998

3836

ZXC86

NOMESCO Finland

Use of endoscopic device

34.7

141.8

186

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

139.5

1337

6162

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

1326.7

133.7

130

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

328.0

128.9

130

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

128.6

1922

10847

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

127.7

2783

18157

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

8.9

126.6

281

329

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

105.1

122.4

134

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.6

118.6

590

1763

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

9.5

118.2

252

275

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

41.2

118.1

149

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

13.2

117.8

212

165

AA1AD

NOMESCO Finland

CT of head and brain

2.2

117.8

1528

8061

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

244.0

117.2

120

R53

ICD-10 Finland

Malaise and fatigue

2.2

115.4

1474

7713

E27.2

ICD-10 Finland

Addisonian crisis

+∞

111.7

107

301

Kela drug reimbursment

Growth hormone

38.0

107.6

138

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

107.5

1944

11659

G47.3

ICD-10 Finland

Sleep apnoea

2.1

106.7

1450

7756

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.9

104.7

365

782

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

992.2

100.3

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

98.1

N05AH04

ATC

quetiapine; oral

2.1

96.9

1254

6535

XCK00

NOMESCO Finland

Perimetry

3.2

96.2

549

1811

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

+∞

96.0

N91.1

ICD-10 Finland

Secondary amenorrhoea

6.4

94.9

261

421

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

94.3

1491

8424

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

93.1

1296

6953

E24.8

ICD-10 Finland

Other Cushing syndrome

+∞

91.8

C03CA01

ATC

furosemide; systemic

2.0

91.6

1496

8543

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

19.0

91.5

142

E22.80

ICD-10 Finland

Central precocious puberty

458.5

91.4

R51.80

ICD-10 Finland

Headache

2.1

90.0

1148

5922

E29.1

ICD-10 Finland

Testicular hypofunction

9.8

89.0

185

193

E23.6

ICD-10 Finland

Other disorders of pituitary gland

879.1

88.9

N06AX16

ATC

venlafaxine; oral

2.2

88.7

1046

5209

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

88.7

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

+∞

88.7

E27.9

ICD-10 Finland

Disorder of adrenal gland, unspecified

868.9

87.8

R06.0

ICD-10 Finland

Dyspnoea

1.9

87.8

1534

8959

N06AX21

ATC

duloxetine; oral

2.4

87.0

808

3580

H53.4

ICD-10 Finland

Visual field defects

5.7

85.2

255

458

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

84.5

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

84.0

1209

6540

N05BA04

ATC

oxazepam; oral

1.9

83.7

1620

9789

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

64.8

82.7

121

Kela drug reimbursment

Severe hypofunction of sexual glands

5.7

82.4

247

445

N06AX11

ATC

mirtazapine; oral

1.8

81.3

2020

13224

A02BC02

ATC

pantoprazole; systemic

1.6

79.3

3884

30683

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

79.2

679

2876

Y28

ICPC

Limited function/disability (Y)

20.7

77.0

116

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

76.9

1804

11560

N03AX16

ATC

pregabalin; oral

1.9

76.5

1462

8751

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

74.3

730

3316

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

74.1

969

5015

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

74.0

852

4171

H02AB06

ATC

prednisolone; systemic

1.6

73.1

2857

21089

N03AX12

ATC

gabapentin; oral

2.0

73.0

1003

5297

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

72.0

N06AB04

ATC

citalopram; systemic

1.8

71.9

1387

8303

G02CB04

ATC

quinagolide; oral

355.7

70.7

E34.35

ICD-10 Finland

Abnormal growth retardation

11.9

69.9

131

112

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

68.5

1331

7974

N02AX02

ATC

tramadol; systemic, rectal

1.6

68.1

2459

17678

UJF32

NOMESCO Finland

Coloscopy

1.8

67.9

1500

9365

BCA30

NOMESCO Finland

Unilateral adrenalectomy

53.9

67.0

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

65.9

921

4878

E25.9

ICD-10 Finland

Adrenogenital disorder, unspecified

643.8

65.0

N05CF01

ATC

zopiclone; oral

1.7

64.6

1858

12513

E23.08

ICD-10 Finland

Hypopituitarism

+∞

63.6

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

63.5

1198

7079

C07AB07

ATC

bisoprolol; oral

1.6

62.9

2448

17829

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

62.6

1386

8629

R11

ICD-10 Finland

Nausea and vomiting

2.4

62.2

597

2670

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

61.6

2277

16347

2542

FHL

Transasal hypophysectomy

+∞

61.5

D35.30

ICD-10 Finland

Craniopharyngoma

211.7

61.2

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

60.7

588

2640

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

60.4

753

3798

N02AA05

ATC

oxycodone; systemic

2.0

60.0

812

4236

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

16.3

60.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

59.9

757

3838

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

59.4

622

2899

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

+∞

59.4

A02BC05

ATC

esomeprazole; systemic

1.6

59.2

2359

17210

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

59.0

2481

18333

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

58.9

1002

5698

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

58.9

900

4922

J01MA12

ATC

levofloxacin; systemic

1.8

58.3

1069

6241

A02BC01

ATC

omeprazole; systemic

1.7

58.3

1598

10566

C03DA01

ATC

spironolactone; oral

2.3

58.1

610

2846

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

57.8

962

5425

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

57.7

752

3860

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

57.5

561

2525

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

57.5

581

2659

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

57.4

605

2825

25898

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti

+∞

57.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

56.8

408

1554

R50.9

ICD-10 Finland

Fever, unspecified

1.9

56.8

968

5502

N02BE01

ATC

paracetamol; systemic, rectal

1.6

56.8

5272

46583

G03DB01

ATC

dydrogesterone; oral

2.0

56.7

862

4697

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

562.2

56.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

56.4

603

2832

N03AX09

ATC

lamotrigine; oral

2.7

56.1

404

1542

T99

ICPC

Endocr/metab/nutrit disease other

5.6

56.1

169

307

N06AA09

ATC

amitriptyline; systemic

2.2

55.7

626

3010

N05BA01

ATC

diazepam; systemic, rectal

2.0

55.4

835

4535

N05CD07

ATC

temazepam; oral

2.1

55.2

687

3452

SPAT1262

SPAT

Handing over of treatment supplies

1.8

55.0

1055

6238

N03AE01

ATC

clonazepam; systemic

2.6

55.0

419

1652

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

54.5

517

2290

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

54.4

1232

7678

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

54.1

1213

7534

E23.0

ICD-10 Finland

Hypopituitarism

531.7

53.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

53.4

2869

22259

E66.8

ICD-10 Finland

Other obesity

2.7

53.3

398

1550

J01FF01

ATC

clindamycin; systemic

1.6

53.1

1616

10943

N03AG01

ATC

valproic acid; systemic, rectal

2.4

52.3

475

2058

A06AD11

ATC

lactulose; oral

2.0

52.3

782

4225

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

+∞

52.1

E27.8

ICD-10 Finland

Other specified disorders of adrenal gland

+∞

52.1

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

52.0

647

3247

N05AH03

ATC

olanzapine; systemic

2.4

51.9

456

1942

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

51.2

471

2052

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

51.1

1171

7307

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

50.4

2568

19615

J01MA02

ATC

ciprofloxacin; systemic

1.5

50.0

2172

15999

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

4.0

50.0

207

525

R42

ICD-10 Finland

Dizziness and giddiness

1.7

49.5

1200

7607

R03AC02

ATC

salbutamol; inhalant

1.5

49.2

3253

26200

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

49.1

831

4691

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

49.1

1094

6762

E23.7

ICD-10 Finland

Disorder of pituitary gland, unspecified

251.8

49.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

48.9

1467

9862

J01DB01

ATC

cefalexin; oral

1.5

48.6

5170

45949

R03BB04

ATC

tiotropium bromide; inhalant

2.2

48.6

537

2556

TAB00

NOMESCO Finland

Lumbar puncture

2.7

48.3

358

1388

N06AB10

ATC

escitalopram; oral

1.7

48.0

1301

8506

25899

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system

+∞

47.9

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

128.3

47.8

N05AX08

ATC

risperidone; systemic

2.2

47.8

508

2376

SPAT1254

SPAT

Administration of medicine

1.8

47.7

925

5465

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

47.5

746

4097

L28

ICPC

Limited function/disability (L)

1.9

47.4

831

4747

ZXC95

NOMESCO Finland

Use of surgical navigator

6.1

47.0

132

220

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.4

47.0

235

699

M05BA04

ATC

alendronic acid; oral

2.4

46.8

437

1918

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

+∞

45.9

25510

ICD-8 Finland

Diseases of adrenal glands, Adrenal cortical hypofunction

+∞

45.9

104

Kela drug reimbursment

Thyroid insufficiency

2.3

45.8

457

2074

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

45.3

1373

9226

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

45.1

608

3147

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

44.9

555

2773

2533

FHL

Unilateral removal of additional egg

+∞

44.8

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

44.6

2663

20853

R03DC03

ATC

montelukast; oral

1.7

44.5

1015

6299

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

44.3

1603

11252

SPAT1263

SPAT

Sampling

1.5

44.1

2578

20084

N05AA02

ATC

levomepromazine; systemic

2.8

43.9

302

1118

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

43.8

1287

8569

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

43.7

598

3111

G44.2

ICD-10 Finland

Tension-type headache

1.8

43.1

832

4897

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

43.1

473

2243

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

42.4

196

547

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

42.4

492

2391

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

42.3

2029

15145

C07AA05

ATC

propranolol; systemic

1.6

42.2

1197

7886

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

42.0

585

3066

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

41.8

452

2128

2551A

ICD-9 Finland

Disorders of adrenal glands, Hyperaldosteronism

+∞

41.7

ZX120

NOMESCO Finland

Intravenous

2.0

41.5

591

3120

R60.0

ICD-10 Finland

Localized oedema

2.0

41.3

608

3254

C08CA01

ATC

amlodipine; oral

1.5

41.1

1705

12309

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

41.0

402

1807

E25.00

ICD-10 Finland

Congenital salt-losing adrenal hyperplasia

+∞

40.6

E25.01

ICD-10 Finland

Congenital adrenal hyperplasia

+∞

40.6

A10BA02

ATC

metformin; oral

1.6

40.6

1353

9275

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

40.6

1262

8502

R03AK08

ATC

formoterol and beclometasone; inhalant

2.9

40.5

260

920

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

40.5

1346

9222

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

40.3

372

1622

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

40.0

2131

16207

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

39.9

1154

7629

SPAT1301

SPAT

No procedures

1.5

39.7

1832

13516

A02BC03

ATC

lansoprazole; oral

1.5

39.7

1565

11155

E24.2

ICD-10 Finland

Drug-induced Cushing syndrome

+∞

39.6

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

39.2

238

814

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.6

39.2

183

516

E0000UV

ATC

1.4

39.1

2353

18312

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

39.0

938

5893

WX110

NOMESCO Finland

Local anesthesy

1.4

38.9

4327

37669

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

86.5

38.8

M79.6

ICD-10 Finland

Pain in limb

1.5

38.7

1998

15075

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

38.7

325

1352

A02BA02

ATC

ranitidine; systemic

1.6

38.6

1034

6692

22620

ICD-8 Finland

Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)

+∞

38.6

N06AB03

ATC

fluoxetine; oral

1.8

38.5

770

4573

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

38.3

327

1370

A46

ICD-10 Finland

Erysipelas

1.8

38.0

716

4175

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.6

38.0

100

154

R03BA05

ATC

fluticasone; inhalant

1.6

37.8

1129

7517

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

37.5

608

3367

CS494

NOMESCO Finland

Other visual field testing

3.8

37.4

166

449

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.9

37.0

236

834

A07AA02

ATC

nystatin; oral

2.3

36.7

363

1638

N05AX12

ATC

aripiprazole; systemic

2.5

36.6

298

1216

M54.5

ICD-10 Finland

Low back pain

1.5

36.6

1888

14209

S18

ICPC

Laceration/cut

1.4

36.5

2292

17913

2535A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus

+∞

36.5

SPAT1153

SPAT

Removal of sutures

1.5

36.4

1705

12573

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

36.2

249

922

H01CB02

ATC

octreotide; parenteral

16.7

36.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

36.2

1012

6616

H02AB04

ATC

methylprednisolone; systemic

1.7

35.9

826

5115

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

35.8

329

1433

J01MA14

ATC

moxifloxacin; systemic

2.0

35.5

506

2669

N06AB06

ATC

sertraline; oral

1.8

35.1

694

4098

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

35.0

763

4648

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

35.0

486

2537

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

34.8

381

1801

J02AC01

ATC

fluconazole; systemic

1.4

34.6

2308

18192

H47.2

ICD-10 Finland

Optic atrophy

9.7

34.6

25320

ICD-8 Finland

Diseases of pituitary gland, Chromophobe adenoma, pituitary

+∞

34.4

E23.3

ICD-10 Finland

Hypothalamic dysfunction, not elsewhere classified

+∞

34.4

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.3

34.3

107

204

A55

ICPC

General and Unspecified, Local injection/infiltration

5.7

34.3

101

180

A28

ICPC

Limited function/disability NOS

1.8

34.3

676

3991

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

34.2

602

3427

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

34.2

461

2378

J46

ICD-10 Finland

Status asthmaticus

3.1

33.7

197

658

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

33.7

2346

18608

BC1AD

NOMESCO Finland

CT of adrenal glands

7.2

33.6

117

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

33.6

538

2961

UKC02

NOMESCO Finland

Cystoscopy

1.7

33.6

764

4707

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

33.4

324

1446

2370A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct

+∞

33.3

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

33.2

1555

11431

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

32.8

230

863

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

32.7

1502

10992

R03DA04

ATC

theophylline; systemic, rectal

2.4

32.7

283

1195

R55

ICD-10 Finland

Syncope and collapse

1.8

32.6

565

3195

N05BA12

ATC

alprazolam; oral

1.8

32.6

586

3356

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

32.5

302

1322

N06AB05

ATC

paroxetine; oral

2.1

32.3

396

1964

JN4BD

NOMESCO Finland

Extensive body CT

1.8

32.3

557

3146

A10AE04

ATC

insulin glargine; parenteral

1.9

32.3

508

2776

H01CB03

ATC

lanreotide; parenteral

17.1

32.2

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

6.2

32.2

143

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

32.1

782

4907

R03AC12

ATC

salmeterol; inhalant

2.5

31.9

263

1082

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

318.3

31.9

-50

ICPC

Medication/prescr/renewal

2.5

31.8

261

1069

SPAT1216

SPAT

Assessment of functional ability

1.7

31.8

755

4709

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

31.7

1780

13535

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

31.7

750

4670

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

31.6

1714

12950

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

31.6

288

1250

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

31.3

347

1649

2554A

ICD-9 Finland

Disorders of adrenal glands, Corticoadrenal insufficiency[MORBUS ADDISON PRIMARIUS]

+∞

31.3

2532A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]

+∞

31.3

E23.1

ICD-10 Finland

Drug-induced hypopituitarism

+∞

31.3

2530A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]

+∞

31.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

31.2

477

2580

R01AD08

ATC

fluticasone; nasal

1.4

31.2

1645

12353

WX882

NOMESCO Finland

High dependency care

2.6

31.2

241

956

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

31.0

209

766

WZC30

NOMESCO Finland

Teaching

1.7

30.9

723

4487

N06AX26

ATC

vortioxetine; oral

2.1

30.9

372

1832

N04BC01

ATC

bromocriptine; oral

70.1

30.8

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

30.8

1646

12389

N06AX12

ATC

bupropion; oral

2.0

30.8

410

2104

A11CC03

ATC

alfacalcidol; systemic

3.2

30.7

168

537

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

30.5

482

2636

ZX114

NOMESCO Finland

Intramuscular

3.8

30.4

133

357

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

4.1

30.3

122

304

V04CD01

ATC

metyrapone; oral

+∞

30.2

25390

ICD-8 Finland

Diseases of pituitary gland, Diabetes insipidus

+∞

30.2

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.3

30.1

176

SPAT1310

SPAT

Counselling related to known health issue

1.4

30.1

1823

14033

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

30.1

208

774

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

30.1

278

1215

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

30.0

401

2062

A12BA01

ATC

potassium chloride; oral

2.7

30.0

217

831

S97

ICPC

Chronic ulcer skin

2.3

29.9

279

1224

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

29.8

508

2852

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.7

29.8

132

358

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

29.8

593

3507

T90

ICPC

Diabetes non-insulin dependent

1.5

29.8

1067

7382

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

11.3

29.7

T28

ICPC

Limited function/disability (T)

5.2

29.6

184

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

29.5

552

3198

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

29.4

552

3202

E87.6

ICD-10 Finland

Hypokalaemia

2.9

29.3

190

678

R52.2

ICD-10 Finland

Other chronic pain

2.6

29.3

224

886

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

29.2

530

3040

R03BA08

ATC

ciclesonide; inhalant

1.9

29.2

477

2642

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.9

29.1

123

320

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

29.0

331

1592

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

29.0

3133

26504

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

29.0

2794

23218

RD210

NOMESCO Finland

2.9

28.9

181

634

J45.8

ICD-10 Finland

Mixed asthma

2.7

28.9

209

798

205

Kela drug reimbursment

Chronic hypertension

1.5

28.8

1213

8684

N30.0

ICD-10 Finland

Acute cystitis

1.6

28.7

740

4711

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

28.7

2086

16552

E34.30

ICD-10 Finland

Short stature NOS

13.2

28.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

28.6

362

1822

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

28.5

571

3379

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

28.4

890

5959

R03BA01

ATC

beclometasone; inhalant

1.6

28.4

763

4910

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

28.2

385

1996

UDM02

NOMESCO Finland

Sinoscopy

3.1

28.1

158

515

25800

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Cushing's syndrome

+∞

28.1

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

+∞

28.1

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

28.1

204

781

J01DA01

ATC

[U] cefalexin; systemic

1.3

28.0

3615

31341

B01AB05

ATC

enoxaparin; parenteral

1.4

28.0

1500

11262

A04

ICPC

Weakness/tiredness general

1.6

27.8

730

4670

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

27.8

388

2029

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

27.4

414

2227

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

27.4

267

1195

SPAT1240

SPAT

Therapeutic discussion

1.6

27.4

683

4309

E30.1

ICD-10 Finland

Precocious puberty

15.1

27.2

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

27.2

224

923

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

27.1

241

1034

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

27.0

1277

9347

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

26.9

416

2256

WX723

NOMESCO Finland

CPAP therapy

2.5

26.9

218

890

N03AX11

ATC

topiramate; oral

2.7

26.8

192

730

M25.5

ICD-10 Finland

Pain in joint

1.4

26.7

1579

12052

Z00.0

ICD-10 Finland

General medical examination

1.5

26.7

1016

7106

SPAT1229

SPAT

Assessment of need for aid

1.9

26.7

385

2039

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

26.7

260

1166

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

10.5

26.6

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

26.6

436

2416

H02AB07

ATC

prednisone; oral

1.6

26.5

736

4771

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

26.3

586

3580

N05BE01

ATC

buspirone; oral

2.6

26.3

194

752

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

29.3

26.2

C08CA13

ATC

lercanidipine; oral

1.7

26.2

595

3653

J01FA06

ATC

roxithromycin; oral

1.3

26.2

2199

17793

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

26.2

177

651

N05AB03

ATC

perphenazine; systemic, rectal

2.4

26.2

229

974

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.5

26.1

204

817

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

4.1

26.1

103

253

L01XX23

ATC

mitotane; oral

+∞

26.0

E24.3

ICD-10 Finland

Ectopic ACTH syndrome

+∞

26.0

M05BX04

ATC

denosumab; parenteral

2.3

25.9

242

1063

A01AB09

ATC

miconazole; local oral

1.8

25.9

471

2699

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

25.9

270

1247

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

11.5

25.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

25.8

1279

9440

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

25.7

897

6149

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

25.7

350

1813

SPAT1260

SPAT

Consultation of another employee

1.5

25.5

988

6926

Z71.8

ICD-10 Finland

Other specified counselling

1.4

25.5

1394

10477

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

25.5

287

1375

R96

ICPC

Asthma

1.8

25.4

472

2727

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

25.4

284

1358

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

25.3

1983

15847

WX402

NOMESCO Finland

General anaesthesia

1.5

25.3

963

6731

R01AD09

ATC

mometasone; nasal

1.3

25.2

2614

21807

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

25.2

329

1675

P01AB01

ATC

metronidazole; oral, rectal

1.3

25.1

2166

17569

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

25.1

504

2980

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

25.0

425

2382

E27

ICD-10 Finland

Other disorders of adrenal gland

+∞

25.0

318

Kela drug reimbursment

Teriparatide

8.4

24.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

24.9

409

2267

H05AA02

ATC

teriparatide; parenteral

8.9

24.9

J01FA10

ATC

azithromycin; systemic

1.3

24.9

3533

30809

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

24.8

161

578

A12AA04

ATC

calcium carbonate; oral

3.5

24.8

117

336

R06AE07

ATC

cetirizine; oral

1.3

24.8

2545

21188

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

24.7

404

2237

ZXA10

NOMESCO Finland

Bilateral

1.5

24.6

973

6847

G03GA01

ATC

chorionic gonadotrophin; parenteral

2.3

24.6

239

1071

E26.0

ICD-10 Finland

Primary hyperaldosteronism

7.3

24.6

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

24.4

193

779

N05CF02

ATC

zolpidem; oral

1.5

24.3

945

6630

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

24.2

551

3380

C07AB02

ATC

metoprolol; systemic

1.5

24.2

924

6454

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.7

24.2

107

291

R06.5

ICD-10 Finland

Mouth breathing

1.7

24.2

499

2974

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

24.2

228

1008

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

24.1

1037

7429

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

24.1

545

3341

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

24.1

240

1089

N06AX03

ATC

mianserin; oral

2.2

24.0

260

1224

J01AA02

ATC

doxycycline; systemic

1.3

24.0

4441

40088

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

+∞

24.0

25500

ICD-8 Finland

Diseases of adrenal glands, Aldosteronismus. Syndroma Conn

+∞

24.0

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

23.9

330

1717

N05AN01

ATC

lithium; oral

2.6

23.8

176

684

M48.0

ICD-10 Finland

Spinal stenosis

1.7

23.8

524

3187

Z31.5

ICD-10 Finland

Genetic counselling

2.0

23.8

333

1742

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

23.7

181

716

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

23.7

692

4540

L04AA06

ATC

mycophenolic acid; systemic

3.1

23.6

130

419

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

23.6

249

1156

R35

ICD-10 Finland

Polyuria

2.0

23.6

322

1668

J01FA09

ATC

clarithromycin; systemic

1.4

23.6

1789

14187

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

23.6

2370

19622

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

23.6

321

1661

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

23.4

1289

9680

N05AF03

ATC

chlorprothixene; systemic

2.5

23.4

182

726

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

23.4

677

4431

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

23.4

440

2553

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

23.3

156

571

C09CA06

ATC

candesartan; oral

1.4

23.2

1064

7715

C01CA24

ATC

epinephrine; parenteral

1.9

23.2

372

2046

E86

ICD-10 Finland

Volume depletion

3.0

23.1

137

465

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

23.1

238

1095

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

23.1

303

1548

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

23.1

1626

12739

M79.7

ICD-10 Finland

Fibromyalgia

2.4

23.0

194

810

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

23.0

291

1462

25398

ICD-8 Finland

Diseases of pituitary gland, Alii definiti

+∞

22.9

2270A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Adrenal gland

+∞

22.9

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

22.9

640

4149

H53.2

ICD-10 Finland

Diplopia

2.6

22.9

174

688

L17

ICPC

Foot/toe symptom/complaint

1.4

22.9

1333

10105

E34.31

ICD-10 Finland

Short stature, prenatal disorder

14.7

22.9

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.6

22.8

121

R02

ICPC

Shortness of breath/dyspnoea

1.6

22.8

608

3898

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

22.7

502

3057

N03AX14

ATC

levetiracetam; systemic

2.5

22.7

181

732

WX002

NOMESCO Finland

Sedation and analgesia

1.5

22.7

981

7026

N06AG02

ATC

moclobemide; oral

2.1

22.7

255

1222

SPAT1255

SPAT

Intravenous administration of medicine

1.9

22.7

344

1853

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

22.6

605

3881

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

22.6

152

560

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

22.5

132

445

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

22.5

349

1897

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

22.5

302

1556

XLA10

NOMESCO Finland

2.0

22.4

283

1423

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.1

22.4

126

413

XKD00

NOMESCO Finland

Uroflowmetry

1.6

22.4

659

4332

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

22.2

136

472

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

22.2

375

2100

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.2

22.2

120

383

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

22.1

728

4910

C10AA05

ATC

atorvastatin; oral

1.3

22.1

1676

13272

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

22.0

927

6602

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

22.0

335

1808

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

22.0

288

1471

25300

ICD-8 Finland

Diseases of pituitary gland, Aeromegalia

+∞

21.9

UDC00

NOMESCO Finland

Ear microscopy

1.8

21.9

407

2353

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

21.8

492

3012

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

21.8

681

4538

L03

ICPC

Low back symptom/complaint

1.4

21.8

1271

9628

N03AF01

ATC

carbamazepine; oral, rectal

2.0

21.7

279

1412

C09CA01

ATC

losartan; oral

1.4

21.6

1087

8013

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

21.6

406

2354

L04AX01

ATC

azathioprine; systemic

2.0

21.6

274

1381

R33

ICD-10 Finland

Retention of urine

1.9

21.5

333

1806

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

21.5

292

1511

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

21.4

1224

9237

R03BA02

ATC

budesonide; inhalant

1.5

21.4

956

6887

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

21.2

374

2125

F34.1

ICD-10 Finland

Dysthymia

2.2

21.2

222

1031

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

21.1

747

5122

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.7

21.1

259

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

21.1

137

493

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

21.0

788

5469

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

20.9

230

1089

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

5.8

20.9

102

25399

ICD-8 Finland

Diseases of pituitary gland, Other and unspecified

+∞

20.8

J01EA01

ATC

trimethoprim; systemic

1.4

20.8

1272

9705

A01

ICPC

Pain general/multiple sites

1.8

20.8

399

2327

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

20.7

243

1186

SPAT1312

SPAT

General health counselling

1.3

20.7

1862

15096

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

20.7

1429

11125

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

20.7

1169

8796

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

20.6

356

2009

N06AA10

ATC

nortriptyline; systemic

2.7

20.6

139

513

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

20.5

851

6034

R01AD12

ATC

fluticasone furoate; nasal

1.3

20.5

1703

13640

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

20.5

253

1261

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

20.5

205

934

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

20.5

706

4814

A03FA02

ATC

cisapride; oral, rectal

1.8

20.4

368

2103

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

20.4

227

1085

J45

ICD-10 Finland

Asthma

1.6

20.3

525

3332

J01CA04

ATC

amoxicillin; systemic

1.3

20.3

5062

46940

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.6

20.3

147

567

R03DC01

ATC

zafirlukast; oral

3.3

20.2

102

310

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

20.2

143

544

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

20.2

274

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.2

20.1

106

333

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

20.1

205

942

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

20.0

238

1171

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

19.9

251

1262

M03BX02

ATC

tizanidine; oral

1.3

19.9

3491

30875

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

19.9

184

805

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

19.9

117

397

C10AC01

ATC

colestyramine; oral

2.5

19.8

153

610

R52.9

ICD-10 Finland

Pain, unspecified

1.7

19.8

442

2696

25310

ICD-8 Finland

Diseases of pituitary gland, Panhypopituitarismus

+∞

19.8

2550A

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SDR CUSHING E HYPERPLASIA GLANDULAE SUPRARENALI]

+∞

19.8

E22.88

ICD-10 Finland

Other hyperfunction of pituitary gland

+∞

19.8

I15.2

ICD-10 Finland

Hypertension secondary to endocrine disorders

15.3

19.7

R01AD01

ATC

beclometasone; nasal

1.5

19.7

814

5769

XF404

NOMESCO Finland

Ambulatory ECG

1.7

19.6

462

2861

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

6.8

19.6

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

19.6

347

1971

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

19.6

787

5539

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

19.6

452

2785

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

29.0

19.6

P76

ICPC

Depressive disorder

1.8

19.6

368

2131

127

Kela drug reimbursment

Transplant complication

3.0

19.6

115

390

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

19.5

1008

7452

SPAT1325

SPAT

Vaccination

1.3

19.5

1822

14825

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

6.4

19.5

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

19.5

220

1057

I95.9

ICD-10 Finland

Hypotension, unspecified

3.8

19.4

216

E000001

ATC

1.4

19.4

1147

8690

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

19.4

381

2240

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

19.4

317

1756

A10AE05

ATC

insulin detemir; parenteral

1.8

19.3

313

1727

A10BH01

ATC

sitagliptin; oral

1.7

19.3

414

2497

N03AF02

ATC

oxcarbazepine; oral

2.2

19.3

196

897

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

19.2

279

1482

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

19.2

471

2951

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

19.1

127

465

R63.1

ICD-10 Finland

Polydipsia

7.4

19.1

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

19.1

158

654

T82

ICPC

Obesity

2.1

19.1

219

1060

E87.5

ICD-10 Finland

Hyperkalaemia

3.5

19.0

256

S06.0

ICD-10 Finland

Concussion

1.6

19.0

575

3801

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

19.0

243

1228

R03AC13

ATC

formoterol; inhalant

2.0

18.9

247

1260

SPAT1234

SPAT

Support of social functional capacity

2.0

18.9

243

1233

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

18.9

288

1558

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

18.8

210

1002

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

18.8

133

506

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

18.8

136

524

E25.8

ICD-10 Finland

Other adrenogenital disorders

+∞

18.7

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.6

18.7

244

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

18.7

176

778

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.9

18.7

114

396

N06AA12

ATC

doxepin; systemic

1.9

18.7

262

1374

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

18.6

139

545

K59.0

ICD-10 Finland

Constipation

1.9

18.6

286

1551

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

18.6

434

2681

E89.39

ICD-10 Finland

Postprocedural hypopituitarism, other or several procedures

190.3

18.5

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

18.5

292

1596

WX892

NOMESCO Finland

Monitored bed care

1.7

18.5

384

2296

N04AA02

ATC

biperiden; systemic

2.7

18.4

124

459

D07AC01

ATC

betamethasone; topical

1.3

18.4

1732

14087

A07AA09

ATC

vancomycin; oral

3.8

18.4

207

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

18.3

554

3658

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

18.3

897

6560

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

18.3

105

350

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.1

18.2

206

991

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

18.1

828

5977

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

18.1

500

3230

R07.3

ICD-10 Finland

Other chest pain

1.6

18.1

451

2836

C10AA01

ATC

simvastatin; oral

1.3

18.1

1814

14879

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

17.9

3968

35878

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

17.8

138

553

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

17.8

157

674

N06AX22

ATC

agomelatine; oral

2.5

17.8

141

572

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.7

17.8

126

479

2550X

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]

+∞

17.7

A02BA04

ATC

nizatidine; systemic

1.7

17.7

358

2124

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

17.6

707

4973

WX780

NOMESCO Finland

Remote monitoring CPAP

2.1

17.6

202

979

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

17.6

1563

12598

M01AE02

ATC

naproxen; oral, rectal

1.3

17.5

3297

29209

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

17.5

219

1098

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

180.3

17.5

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

17.4

1345

10616

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

17.4

316

1812

J05AB01

ATC

aciclovir; systemic

1.4

17.3

1073

8177

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

17.3

245

1290

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

17.3

297

1671

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

17.3

174

S10

ICPC

Boil/carbuncle

1.8

17.3

284

1578

SPAT1097

SPAT

Recording of ECG

1.5

17.1

670

4684

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

17.1

189

901

XQ800

NOMESCO Finland

Prick test

1.6

17.1

449

2863

C08CA05

ATC

nifedipine; systemic

1.8

17.1

290

1626

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

17.1

537

3579

M01AH02

ATC

rofecoxib; oral

1.5

17.1

597

4078

E000003

ATC

1.9

17.1

259

1399

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

17.0

239

1255

N06AB08

ATC

fluvoxamine; oral

2.3

17.0

159

702

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

17.0

3137

27695

E29.9

ICD-10 Finland

Testicular dysfunction, unspecified

13.2

16.9

N19

ICD-10 Finland

Unspecified kidney failure

2.4

16.9

145

615

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

16.9

231

1199

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

16.9

521

3457

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

16.8

1463

11740

N05AH02

ATC

clozapine; systemic

2.5

16.8

132

535

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

16.8

646

4504

106

Kela drug reimbursment

Hypoparathyroidism

6.1

16.7

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

16.7

248

1326

AA4DM

NOMESCO Finland

Very extensive MRI examination of sella turcica with 3 Tesla magnet

+∞

16.7

2550B

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERFUNCTIO GLAN SUPRARENALI]

+∞

16.7

P01

ICPC

Feeling anxious/nervous/tense

1.5

16.6

625

4335

M02AA07

ATC

piroxicam; topical

1.3

16.6

1749

14411

R51

ICD-10 Finland

Headache

1.8

16.6

291

1653

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.2

16.5

177

832

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.1

16.5

191

929

D35.59

ICD-10 Finland

Other paragangliom

170.2

16.5

D07AA02

ATC

hydrocortisone; topical

1.4

16.4

769

5570

G43.3

ICD-10 Finland

Complicated migraine

2.8

16.4

105

375

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.4

16.4

141

598

L04AD01

ATC

ciclosporin; systemic

2.5

16.4

128

516

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

16.4

274

1530

M79.1

ICD-10 Finland

Myalgia

1.5

16.3

653

4584

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

16.3

474

3102

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

16.3

3084

27251

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

16.3

131

537

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

16.3

309

ZXA05

NOMESCO Finland

Left side

1.3

16.3

1199

9388

R5599

NOMESCO Finland

Other rehabilitation service

2.2

16.2

163

746

K76.9

ICD-10 Finland

Liver disease, unspecified

3.1

16.2

295

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

5.9

16.2

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

16.2

144

622

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

16.2

296

R03AC03

ATC

terbutaline; inhalant

1.4

16.2

729

5247

JN4AD

NOMESCO Finland

Body CT examination

1.7

16.1

333

1987

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

16.1

154

689

BF20A

NOMESCO Finland

30.1

16.1

R4180

NOMESCO Finland

Podiatric therapy

3.7

16.1

191

SPAT1243

SPAT

Psychiatric/psychological examination

2.1

16.1

188

920

K02.1

ICD-10 Finland

Caries of dentine

1.2

16.1

3371

30110

C08DA01

ATC

verapamil; systemic

2.0

16.0

195

970

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

16.0

203

1024

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.4

16.0

134

C09AA02

ATC

enalapril; systemic

1.4

16.0

826

6095

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.6

16.0

119

468

C09AA05

ATC

ramipril; oral

1.4

15.9

1009

7707

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

15.9

343

2073

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

15.9

157

711

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.5

15.8

123

496

A99

ICPC

Disease/condition unspecnature/site

1.6

15.8

390

2447

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

15.8

143

621

N06AA06

ATC

trimipramine; systemic

2.4

15.8

138

591

A04AA01

ATC

ondansetron; systemic, rectal

1.7

15.8

335

2016

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

15.7

303

1769

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.7

15.7

107

400

R06AE09

ATC

levocetirizine; oral

1.4

15.7

796

5849

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

15.7

329

1973

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

15.7

114

443

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.3

15.7

Y0099

ICD-8 Finland

Investigation of endocrine system and metabolism

5.9

15.6

BCA41

NOMESCO Finland

Endoscopic bilateral adrenalectomy

+∞

15.6

25599

ICD-8 Finland

Diseases of adrenal glands, Other and unspecified

+∞

15.6

AA4AD

NOMESCO Finland

CT of sella turcica

+∞

15.6

R06AX22

ATC

ebastine; oral

1.4

15.6

879

6583

C08CA02

ATC

felodipine; oral

1.6

15.6

371

2306

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

15.6

170

807

E83.50

ICD-10 Finland

Hypercalcemia

3.6

15.5

197

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

15.5

516

3484

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

15.5

266

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

15.5

210

1090

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

6.6

15.5

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.8

15.4

101

369

L29

ICPC

Musculoskeletal sympt/complt other

1.6

15.4

368

2288

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.8

15.4

100

363

J01CA08

ATC

pivmecillinam; oral

1.3

15.4

2044

17302

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

15.3

1071

8306

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

15.3

187

931

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

15.3

137

594

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

15.3

330

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.8

15.2

352

R4190

NOMESCO Finland

Nutritional therapy

1.9

15.2

234

1270

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.9

15.2

309

R03BB01

ATC

ipratropium bromide; inhalant

2.1

15.2

170

818

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

15.2

121

495

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.8

15.1

355

P03

ICPC

Feeling depressed

1.5

15.1

520

3534

S29

ICPC

Skin symptom/complaint other

1.4

15.1

824

6133

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.5

15.1

117

471

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.2

15.1

239

SPAT1252

SPAT

Overall medication plan or its review

1.7

15.1

314

1878

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

15.0

304

1804

C02AC05

ATC

moxonidine; oral

2.0

15.0

200

1030

D35.9

ICD-10 Finland

Benign neoplasm: Endocrine gland, unspecified

45.0

15.0

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

15.0

120

491

T73

ICPC

Neoplasm endocrine other/unspecified

11.8

15.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

15.0

132

568

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

15.0

273

1569

N04BC05

ATC

pramipexole; oral

1.7

15.0

320

1930

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

14.9

712

9408

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

14.9

333

2032

602

Kela drug reimbursment

Children's severe malnutrition

3.8

14.9

168

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.6

14.9

372

2341

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

14.9

311

1863

L04AA01

ATC

[U] ciclosporin; systemic

2.8

14.9

331

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

14.9

455

3013

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.9

14.8

325

SPAT1211

SPAT

Application of soft bandage

1.5

14.8

464

3088

D07AC13

ATC

mometasone; topical

1.3

14.8

1472

12002

-1

NOMESCO Finland

1.3

14.8

1962

16581

G04CA01

ATC

alfuzosin; oral

1.5

14.8

456

3022

N91.2

ICD-10 Finland

Amenorrhoea, unspecified

4.7

14.8

104

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.7

14.7

175

UJD02

NOMESCO Finland

Gastroscopy

1.9

14.7

230

1258

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

14.7

344

2130

TK800

NOMESCO Finland

Hemodialysis

2.5

14.6

117

479

A10BJ02

ATC

liraglutide; parenteral

2.4

14.6

121

506

D352, E221

ICD-10 Finland

+∞

14.6

6116A

ICD-9 Finland

Other disorders of breast, Galactorrhoea not associated with childbirth

+∞

14.6

2533A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Pituitary dwarfism[NANISMUS HYPOPHYSARIUS]

+∞

14.6

Q96.3

ICD-10 Finland

Mosaicism, 45,X/46,XX or XY

+∞

14.6

M03BX01

ATC

baclofen; systemic

2.7

14.6

100

377

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

14.6

126

537

E31.00

ICD-10 Finland

APECED syndrome

80.2

14.6

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.9

14.6

152

C10AX09

ATC

ezetimibe; oral

1.6

14.6

438

2887

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

14.5

292

1729

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.7

14.5

354

WZA90

NOMESCO Finland

Other doctors statement

1.3

14.5

1277

10239

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.9

14.5

148

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

14.5

117

483

J32.4

ICD-10 Finland

Chronic pansinusitis

3.0

14.4

285

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

14.4

835

6275

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

14.4

813

6083

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

14.4

4230

38944

N06AX18

ATC

reboxetine; oral

3.1

14.4

258

N06BA04

ATC

methylphenidate; oral

2.1

14.4

167

816

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

14.4

132

581

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

14.4

116

478

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

14.3

783

5829

L86

ICPC

Back syndrome with radiating pain

1.8

14.3

269

1561

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

14.3

267

1545

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

14.3

544

3781

E28.3

ICD-10 Finland

Primary ovarian failure

6.6

14.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

14.2

308

1864

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

14.2

206

1098

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.4

14.1

123

526

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

14.1

359

2273

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

14.1

1444

11809

L01

ICPC

Neck symptom/complaint

1.4

14.0

680

4954

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.0

14.0

273

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

7.0

14.0

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

14.0

2057

17568

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.7

14.0

368

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

14.0

522

3612

SPAT1139

SPAT

Nutrition survey

2.0

14.0

170

847

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

14.0

2734

24097

N05AF01

ATC

flupentixol; systemic

2.7

13.9

339

A02BC04

ATC

rabeprazole; oral

1.6

13.9

413

2712

WX290

NOMESCO Finland

Other blockade of nerve

1.2

13.9

2567

22479

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

13.9

1068

8392

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

13.9

459

3095

P06

ICPC

Sleep disturbance

1.5

13.9

495

3390

D02AE01

ATC

carbamide; topical

1.6

13.9

342

2147

J01DA06

ATC

[U] cefuroxime; systemic

1.4

13.8

726

5366

N05AD01

ATC

haloperidol; systemic

2.1

13.8

150

710

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.5

13.8

180

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.1

13.8

152

725

J02AC02

ATC

itraconazole; systemic

1.4

13.8

877

6694

V03AE01

ATC

polystyrene sulfonate; oral

3.3

13.8

212

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

13.7

181

928

U04

ICPC

Incontinence urine

1.9

13.7

194

1025

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

13.7

511

3538

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

13.6

131

588

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

13.6

237

1343

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.7

13.6

162

A02BX02

ATC

sucralfate; oral

2.0

13.6

176

900

E24

ICD-10 Finland

Cushing syndrome

75.2

13.6

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

13.6

122

530

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

13.5

449

3030

E25.0

ICD-10 Finland

Congenital adrenogenital disorders associated with enzyme deficiency

+∞

13.5

BC5AQ

NOMESCO Finland

Chromaffine tissue SPECT with low dose CT

+∞

13.5

N97.9

ICD-10 Finland

Female infertility, unspecified

1.7

13.5

265

1557

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

13.5

340

2147

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

13.5

128

573

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

13.5

3287

29591

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.6

13.5

369

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

9.3

13.4

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

13.4

401

2641

C07AG02

ATC

carvedilol; oral

1.8

13.4

239

1365

D75.1

ICD-10 Finland

Secondary polycythaemia

4.5

13.4

102

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

13.4

149

715

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

13.3

116

498

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

13.3

132

602

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

25.7

13.3

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

4.2

13.3

121

R13

ICD-10 Finland

Dysphagia

1.7

13.3

285

1720

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.7

13.3

319

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

13.3

134

617

K03.66

ICD-10 Finland

Tooth plaque

1.6

13.2

370

2400

A10BJ06

ATC

semaglutide; parenteral

2.1

13.2

155

760

OAB72

NOMESCO Finland

Weight control and weight loss guidance

4.4

13.2

108

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.3

13.1

198

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

13.1

166

840

H47.4

ICD-10 Finland

Disorders of optic chiasm

40.1

13.1

JAH01

NOMESCO Finland

Laparoscopy

1.8

13.1

231

1314

XF402

NOMESCO Finland

ECG with work load test

1.5

13.1

477

3284

M02AA10

ATC

ketoprofen; topical

1.4

13.1

723

5389

R01AD05

ATC

budesonide; nasal

1.5

13.1

390

2569

H26.3

ICD-10 Finland

Drug-induced cataract

4.2

13.0

114

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.2

13.0

135

630

P29

ICPC

Psychological sympt/compl other

1.6

13.0

319

2002

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

3.4

13.0

184

J47

ICD-10 Finland

Bronchiectasis

2.7

13.0

342

M54.2

ICD-10 Finland

Cervicalgia

1.6

13.0

341

2178

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

12.9

323

2035

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

12.9

134

624

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

12.9

153

754

RJ410

NOMESCO Finland

5.5

12.9

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

12.9

517

3629

R05FB02

ATC

cough suppressants and expectorants

1.2

12.9

1815

15396

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

12.9

234

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

12.9

377

2471

G72.8

ICD-10 Finland

Other specified myopathies

3.0

12.9

249

N17

ICPC

Vertigo/dizziness

1.5

12.9

501

3495

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.8

12.8

234

1348

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

6.9

12.8

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

12.8

424

2860

R4110

NOMESCO Finland

Physiotherapy

1.3

12.8

1339

10966

G03GA02

ATC

human menopausal gonadotrophin; parenteral

2.2

12.8

126

576

K30

ICD-10 Finland

Functional dyspepsia

1.5

12.7

498

3477

RS221

NOMESCO Finland

2.5

12.7

390

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.0

12.7

158

794

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

12.7

456

3131

WX722

NOMESCO Finland

PEEP

1.8

12.7

216

1218

R05

ICD-10 Finland

Cough

1.3

12.6

966

7575

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

12.6

302

1880

Z01.2

ICD-10 Finland

Dental examination

1.2

12.6

2383

20856

N29

ICPC

Neurological sympt/complt other

2.4

12.6

105

442

2159

FHL

Other measure in this category

69.9

12.6

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

12.5

211

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

12.5

118

525

SPAT1053

SPAT

Memory test

1.4

12.5

515

3636

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

5.0

12.5

N48.4

ICD-10 Finland

Impotence of organic origin

2.4

12.5

102

425

AA400

NOMESCO Finland

Electroconvulsive therapy

3.2

12.5

206

2559X

ICD-9 Finland

Disorders of adrenal glands, Unspecified disorder of adrenal glands

+∞

12.5

9500/3-C74.1

ICD-O-3

Neuroblastoma, NOS, of medulla of adrenal gland

+∞

12.5

AA4BM

NOMESCO Finland

MRI examination of sella turcica with 3 Tesla magnet

+∞

12.5

J01MA01

ATC

ofloxacin; systemic

1.5

12.5

374

2464

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

12.5

267

1611

C03AA03

ATC

hydrochlorothiazide; oral

1.5

12.4

384

2550

G04CA02

ATC

tamsulosin; oral

1.3

12.4

809

6192

DPA30

NOMESCO Finland

Sphenotomy

4.6

12.4

137

Kela drug reimbursment

Uraemia requiring dialysis

3.4

12.4

170

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

12.4

333

2140

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

12.3

624

4580

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.6

12.3

155

A10BK03

ATC

empagliflozin; oral

1.6

12.3

304

1911

M01AB55

ATC

diclofenac, combinations; oral

1.6

12.3

289

1791

C10AA07

ATC

rosuvastatin; oral

1.3

12.3

1014

8035

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

12.3

182

976

F45.0

ICD-10 Finland

Somatization disorder

4.8

12.3

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

12.2

151

N46

ICD-10 Finland

Male infertility

2.8

12.2

270

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

12.2

1204

9775

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

12.2

2079

17985

G93.2

ICD-10 Finland

Benign intracranial hypertension

6.2

12.2

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

12.2

676

5039

SPAT1360

SPAT

Extensive global examination

1.6

12.2

345

2244

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.5

12.2

356

E03

ICD-10 Finland

Other hypothyroidism

1.7

12.2

263

1595

P01BA02

ATC

hydroxychloroquine; oral

1.5

12.2

378

2513

A07DA03

ATC

loperamide; oral

2.0

12.2

161

832

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.1

12.2

139

678

E30.8

ICD-10 Finland

Other disorders of puberty

15.9

12.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

12.1

316

2016

B03XA02

ATC

darbepoetin alfa; parenteral

2.6

12.1

344

-55

ICPC

Local injection/infiltration

4.1

12.1

113

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

12.1

126

590

Z00.8

ICD-10 Finland

Other general examinations

1.6

12.1

354

2320

A01AB04

ATC

amphotericin B; local oral

1.8

12.1

218

1253

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

12.0

396

N05AE04

ATC

ziprasidone; systemic

3.7

12.0

143

XG466

NOMESCO Finland

Sleep oxymetry

2.0

12.0

157

805

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

12.0

361

2384

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

11.0

12.0

J01FA15

ATC

telithromycin; oral

1.5

12.0

491

3461

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.1

12.0

137

667

F60.5

ICD-10 Finland

Anankastic personality disorder

3.0

12.0

224

-69

ICPC

Other reason for encounter NEC

1.9

12.0

185

1009

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

11.9

210

1198

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.8

11.9

206

1167

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

11.9

1387

11489

N07BC02

ATC

methadone; systemic

6.2

11.9

E66

ICD-10 Finland

Obesity

1.7

11.9

222

1287

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.1

11.9

129

612

RS220

NOMESCO Finland

2.5

11.9

378

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.2

11.9

114

515

L16

ICPC

Ankle symptom/complaint

1.4

11.8

510

3635

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

11.8

305

1939

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

11.8

619

8090

P20

ICPC

Memory disturbance

1.5

11.8

415

2836

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

11.8

247

1482

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.5

11.8

156

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.9

11.7

244

F83

ICD-10 Finland

Mixed specific developmental disorders

2.8

11.7

261

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

11.7

358

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.6

11.7

142

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

11.6

363

2418

D07AD01

ATC

clobetasol; topical

1.4

11.6

697

5261

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

11.6

196

1103

H57.1

ICD-10 Finland

Ocular pain

1.9

11.6

171

919

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

11.6

242

1453

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

11.6

228

1346

N02AC04

ATC

dextropropoxyphene; oral

2.0

11.6

150

770

B01AC04

ATC

clopidogrel; oral

1.4

11.6

570

4164

R04.0

ICD-10 Finland

Epistaxis

1.6

11.6

302

1927

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

11.5

239

1431

M05BA07

ATC

risedronic acid; oral

2.0

11.5

134

660

M81.8

ICD-10 Finland

Other osteoporosis

4.0

11.5

114

B01AA03

ATC

warfarin; systemic

1.3

11.5

751

5752

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

7.1

11.5

25508

ICD-8 Finland

Diseases of adrenal glands, Hyperfunctio adrenocorticalis alia

+∞

11.5

Q96.8

ICD-10 Finland

Other variants of Turner syndrome

+∞

11.5

Q96.0

ICD-10 Finland

Karyotype 45,X

+∞

11.5

BC5AN

NOMESCO Finland

Chromaffine and adrenergic tissue isotope imaging (MIBG)

120.1

11.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

11.4

118

549

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.5

11.4

367

T89

ICPC

Diabetes insulin dependent

1.7

11.4

212

1233

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.0

11.3

E000002

ATC

1.4

11.3

605

4485

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

11.3

166

891

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

11.3

292

WX213

NOMESCO Finland

Lower leg blockade

3.5

11.3

146

NXL00

NOMESCO Finland

Biopsy of muscle

6.0

11.3

N06AX05

ATC

trazodone; oral

2.1

11.3

130

637

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

11.2

263

40199

ICD-8 Finland

Essential benign hypertension

2.6

11.2

293

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

11.2

250

1529

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.7

11.2

287

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

11.2

1065

8599

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

11.2

515

3714

U02

ICPC

Urinary frequency/urgency

1.4

11.2

586

4325

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

11.2

621

4632

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.9

11.2

165

889

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

11.1

195

1109

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

4.1

11.1

103

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.3

11.1

169

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

11.1

244

1486

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

11.1

182

1016

A02BB01

ATC

misoprostol; oral

4.3

11.1

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

11.1

1109

9012

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

11.1

848

6645

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

11.0

205

1188

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.2

11.0

181

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.2

11.0

171

SBB10

NOMESCO Finland

Teeth copy

1.5

11.0

413

2863

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

13.9

10.9

N75

ICPC

Benign neoplasm nervous system

13.9

10.9

K92.1

ICD-10 Finland

Melaena

1.8

10.9

199

1149

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.7

10.9

256

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.8

10.9

233

M01AE51

ATC

ibuprofen, combinations; systemic

2.5

10.9

322

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.3

10.9

416

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

10.9

107

489

K07.60

ICD-10 Finland

Snapping jaw

1.6

10.9

253

1568

N06AA04

ATC

clomipramine; systemic

2.4

10.9

360

D01AE15

ATC

terbinafine; topical

1.6

10.8

299

1933

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.1

10.8

189

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

10.8

324

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.5

10.8

324

A06AC51

ATC

ispaghula, combinations; systemic

1.7

10.8

226

1359

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.5

10.8

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

10.8

146

762

R06AX13

ATC

loratadine; oral

1.3

10.8

775

6014

N25.1

ICD-10 Finland

Nephrogenic diabetes insipidus

15.5

10.8

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

10.8

259

1618

B02.9

ICD-10 Finland

Zoster without complication

1.7

10.8

236

1439

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.1

10.7

114

540

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.3

10.7

163

RS222

NOMESCO Finland

2.5

10.7

337

E66.0

ICD-10 Finland

Obesity due to excess calories

3.0

10.7

196

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

10.7

310

2030

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

10.7

767

5955

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

10.7

182

1029

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

10.7

398

2753

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

4.7

10.7

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

10.7

385

2648

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

10.7

127

630

XKC03

NOMESCO Finland

Water cystometry

2.0

10.7

136

694

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

10.7

2233

19653

A29

ICPC

General symptom/complaint other

1.4

10.6

495

3576

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.0

10.6

103

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.1

10.6

122

595

D35.50

ICD-10 Finland

Carotid body

60.0

10.6

E89.31

ICD-10 Finland

Postirradiation hypopituitarism

60.0

10.6

P99

ICPC

Psychological disorders other

1.9

10.6

152

809

L68.0

ICD-10 Finland

Hirsutism

3.7

10.6

123

R52.1

ICD-10 Finland

Chronic intractable pain

3.1

10.6

187

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.8

10.5

186

1061

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

10.5

626

4721

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

10.5

361

N28

ICPC

Limited function/disability (N)

2.7

10.5

268

Y08

ICPC

Sexual function sympt/compl male

4.7

10.5

J05AB11

ATC

valaciclovir; oral

1.4

10.5

612

4599

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

10.5

424

N05AA01

ATC

chlorpromazine; systemic, rectal

2.5

10.5

311

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

10.5

329

B01AB10

ATC

tinzaparin; parenteral

1.6

10.4

287

1856

P72

ICPC

Schizophrenia

2.2

10.4

101

457

T86

ICPC

Hypothyroidism/myxoedema

1.8

10.4

172

962

D35.3

ICD-10 Finland

Benign neoplasm: Craniopharyngeal duct

110.1

10.4

BF10A

NOMESCO Finland

110.1

10.4

E31.08

ICD-10 Finland

Autoimmune polyglandular failure

110.1

10.4

25319

ICD-8 Finland

Diseases of pituitary gland, Hypopituitarismus alia sive NUD

+∞

10.4

M14.5*E22.0

ICD-10 Finland

Arthropathy associated with acromegaly

+∞

10.4

25502

ICD-8 Finland

Diseases of adrenal glands, Virilismus adrenocorticalis

+∞

10.4

E24.4

ICD-10 Finland

Alcohol-induced pseudo-Cushing syndrome

+∞

10.4

25598

ICD-8 Finland

Diseases of adrenal glands, Alii definiti

+∞

10.4

25311

ICD-8 Finland

Diseases of pituitary gland, Hypopituitarismus partialis

+∞

10.4

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

10.4

123

609

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.4

10.4

141

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.1

10.4

111

528

A41.8

ICD-10 Finland

Other specified sepsis

2.5

10.4

306

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

3.5

10.3

136

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

10.3

355

2418

R89.1

ICD-10 Finland

Abnormal findings in specimens from other organs, systems and tissues, abnormal level of hormones

12.0

10.3

R52.0

ICD-10 Finland

Acute pain

1.9

10.3

152

819

RD211

NOMESCO Finland

1.7

10.3

212

1269

M04AA01

ATC

allopurinol; systemic

1.4

10.3

471

3393

R06.2

ICD-10 Finland

Wheezing

1.7

10.3

217

1307

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.6

10.3

283

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

10.3

242

1503

R04

ICPC

Breathing problem other

1.8

10.3

165

916

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

10.2

141

740

BC00A

NOMESCO Finland

10.6

10.2

M01AX17

ATC

nimesulide; oral

1.3

10.2

1070

8732

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.8

10.2

237

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.1

10.2

110

525

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.2

10.2

437

R00.2

ICD-10 Finland

Palpitations

1.5

10.2

328

2198

G91.1

ICD-10 Finland

Obstructive hydrocephalus

4.7

10.2

R62.0

ICD-10 Finland

Delayed milestone

2.7

10.2

261

G44.0

ICD-10 Finland

Cluster headache syndrome

2.7

10.2

244

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

10.2

322

2151

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.2

334

2252

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

10.2

132

678

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.7

10.1

295

4237

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

10.1

677

5196

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

5.4

10.1

L14

ICPC

Leg/thigh symptom/complaint

1.5

10.1

325

2180

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.7

10.1

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

10.1

102

475

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

6.9

10.0

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

10.0

167

938

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.7

10.0

185

1071

7834C

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]

11.3

10.0

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3.7

10.0

114

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

10.0

290

1901

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.4

10.0

140

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.6

10.0

283

F40.1

ICD-10 Finland

Social phobias

1.9

10.0

133

692

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

14.6

10.0

E000006

ATC

1.5

10.0

327

2204

ZXA00

NOMESCO Finland

Right side

1.2

10.0

1222

10162

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.2

10.0

449

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.3

9.9

146

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

9.9

120

602

SPAT1167

SPAT

Insertion of urinary catheter

2.0

9.9

120

602

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

9.9

1812

15717

R15

ICD-10 Finland

Faecal incontinence

2.1

9.9

108

518

NF1DA

NOMESCO Finland

X-ray of hips

2.2

9.9

451

K90

ICPC

Stroke/cerebrovascular accident

2.2

9.9

100

463

D11

ICPC

Diarrhoea

1.4

9.9

577

4335

H26.2

ICD-10 Finland

Complicated cataract

2.6

9.9

261

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.9

9.9

150

817

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

9.9

432

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.8

9.9

208

F45.39

ICD-10 Finland

Somatoform autonomic dysfunction multiple or indeterminate organs

16.7

9.9

BC1BD

NOMESCO Finland

Extensive CT of adrenal glands

12.2

9.8

R49.08

ICD-10 Finland

Other specified dysphonia

2.2

9.8

100

467

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.9

9.8

203

C05AA08

ATC

fluocortolone; rectal, topical

1.3

9.8

651

4994

-44

ICPC

Preventive immunization/medic

1.5

9.8

358

2470

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

4.4

9.8

N62

ICD-10 Finland

Hypertrophy of breast

1.7

9.8

197

1176

B37.08

ICD-10 Finland

Other candidal stomatitis

3.5

9.7

122

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

9.7

143

769

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

9.5

9.7

Q53.2

ICD-10 Finland

Undescended testicle, bilateral

9.5

9.7

SPAT1131

SPAT

Colonoscopy

1.9

9.7

139

741

SPAT1377

SPAT

Polysomnography

1.8

9.7

155

861

K08.3

ICD-10 Finland

Retained dental root

1.5

9.7

303

2022

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

9.7

247

1569

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.8

9.7

221

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

9.7

108

523

R60.1

ICD-10 Finland

Generalized oedema

3.5

9.7

123

L02AE02

ATC

leuprorelin; implant, parenteral

1.7

9.6

176

1018

WW200

NOMESCO Finland

Immunization

1.9

9.6

142

766

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.5

9.6

287

G72.9

ICD-10 Finland

Myopathy, unspecified

3.4

9.6

134

A12AA06

ATC

calcium lactate gluconate; oral

7.8

9.6

R31

ICD-10 Finland

Unspecified haematuria

1.5

9.6

367

2558

M54.3

ICD-10 Finland

Sciatica

1.6

9.6

257

1654

AN1

Coronary angiography

1.4

9.6

424

3037

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

9.5

125

645

S21

ICPC

Skin texture symptom/complaint

1.4

9.5

556

4178

WX730

NOMESCO Finland

Conventional respirator

2.3

9.5

354

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

9.5

159

895

49300

ICD-8 Finland

Asthma, bronchiale

2.0

9.5

110

542

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

9.5

149

819

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.8

9.5

159

896

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

9.5

411

2933

D84.18

ICD-10 Finland

Other specified defect in the complement system

9.1

9.5

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.7

9.5

338

4690

B03XA01

ATC

erythropoietin; parenteral

3.1

9.5

163

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.5

9.4

322

2187

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.0

9.4

111

549

SPAT1058

SPAT

PEF monitoring instruction

1.5

9.4

368

2572

Z50.1

ICD-10 Finland

Other physical therapy

1.6

9.4

238

1506

N05AC02

ATC

thioridazine; oral

2.1

9.4

102

489

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.5

9.4

285

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

9.4

132

698

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

9.4

312

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

9.4

241

1534

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

3.4

9.4

126

G04BD11

ATC

fesoterodine; oral

2.0

9.4

113

565

Y50

ICPC

Male Genital, Medication/prescr/renewal

7.5

9.4

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

3.1

9.4

164

S50

ICPC

Skin, Medication/prescr/renewal

3.5

9.4

121

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

3.5

9.4

121

AA4CD

NOMESCO Finland

Very extensive CT of sella turcica

+∞

9.4

2550C

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]

+∞

9.4

25810

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction

+∞

9.4

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.8

9.4

204

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

9.3

363

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

9.3

626

4806

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.7

9.3

173

1005

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

9.3

332

2278

TGC00

NOMESCO Finland

Bronchial lavation

2.0

9.3

113

569

N05CD02

ATC

nitrazepam; oral

2.4

9.3

307

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.6

9.3

239

N05AL01

ATC

sulpiride; systemic

2.4

9.3

327

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.9

9.3

187

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.8

9.3

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.8

9.2

M01AX01

ATC

nabumetone; oral

1.7

9.2

176

1035

N91.5

ICD-10 Finland

Oligomenorrhoea, unspecified

4.0

9.2

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.3

9.2

134

E30.9

ICD-10 Finland

Disorder of puberty, unspecified

13.6

9.2

A03

ICPC

Fever

1.3

9.1

900

7285

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.1

606

4647

A10AA01

ATC

1.9

9.1

136

737

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

9.1

415

SPAT1104

SPAT

Monitoring of emergency patient

1.5

9.1

293

1966

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

9.1

598

4582

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

7.7

9.1

K29.6

ICD-10 Finland

Other gastritis

2.9

9.1

190

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

9.1

284

1897

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

9.1

332

2293

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

3.6

9.1

109

H47.1

ICD-10 Finland

Papilloedema, unspecified

3.6

9.1

109

N07CA01

ATC

betahistine; oral

1.5

9.1

288

1930

H46

ICD-10 Finland

Optic neuritis

2.9

9.0

185

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.2

9.0

136

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

9.0

224

1416

F50.0

ICD-10 Finland

Anorexia nervosa

3.1

9.0

147

SPAT1281

SPAT

Other administrative function

1.4

9.0

387

2760

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.8

9.0

WX610

NOMESCO Finland

Patient controlled analgesia

3.3

8.9

126

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.0

8.9

159

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

8.9

150

849

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.3

8.9

332

F60.8

ICD-10 Finland

Other specific personality disorders

3.1

8.9

148

SPAT1172

SPAT

Guidance concerning hydration

2.2

8.9

373

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.1

8.9

439

D12

ICPC

Constipation

1.9

8.9

134

729

F31

ICD-10 Finland

Bipolar affective disorder

2.4

8.9

303

WX320

NOMESCO Finland

Spinalanesthesy

1.3

8.9

992

8154

U05

ICPC

Urination problems other

1.7

8.9

188

1136

R30.0

ICD-10 Finland

Dysuria

1.7

8.9

169

991

A27

ICPC

Fear of other disease NOS

1.7

8.9

195

1194

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.2

8.9

407

H05.2

ICD-10 Finland

Exophthalmic conditions

5.4

8.9

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.7

8.9

164

956

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

8.9

109

551

R09

ICPC

Sinus symptom/complaint

1.4

8.9

373

2648

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

8.8

805

6454

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

8.8

122

646

N05AE03

ATC

sertindole; oral

4.8

8.8

E30.09

ICD-10 Finland

Delayed puberty NOS

6.8

8.8

M89.0

ICD-10 Finland

Algoneurodystrophy

2.9

8.8

176

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.8

8.8

189

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

8.8

204

1268

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.0

8.8

161

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

8.8

111

569

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.5

8.8

272

B02AA02

ATC

tranexamic acid; systemic

1.3

8.7

686

5390

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.9

8.7

117

612

W19

ICD-10 Finland

Unspecified fall

1.4

8.7

434

3177

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.4

8.7

300

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.0

8.7

112

575

Y99

ICPC

Genital disease male other

5.6

8.7

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

8.7

504

3787

G04BD12

ATC

mirabegron; oral

1.4

8.7

375

2673

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.2

8.7

383

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

8.7

221

1407

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.2

8.7

363

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.8

8.7

191

L12

ICPC

Hand/finger symptom/complaint

1.3

8.7

682

5359

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

8.7

631

4908

M01AC01

ATC

piroxicam; systemic, rectal

1.3

8.6

556

4246

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

8.6

333

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

8.6

377

2695

B35.3

ICD-10 Finland

Tinea pedis

1.7

8.6

174

1040

J01DC02

ATC

cefuroxime; systemic

1.5

8.6

280

1887

G04BD07

ATC

tolterodine; oral

1.7

8.6

186

1134

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.5

8.6

NHQ40

NOMESCO Finland

Amputation of toe

2.4

8.6

295

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.1

8.6

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

8.6

154

886

R03BC03

ATC

nedocromil; inhalant

1.5

8.6

310

2135

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

6.1

8.6

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

8.6

111

572

N02CC04

ATC

rizatriptan; oral

1.5

8.6

279

1878

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

5.8

8.6

62600

ICD-8 Finland

Disorders of menstruation, Absent

5.5

8.6

L60.0

ICD-10 Finland

Ingrowing nail

1.6

8.6

197

1223

K65.0

ICD-10 Finland

Acute peritonitis

2.8

8.5

181

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.4

8.5

115

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

8.5

107

548

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.3

8.5

340

L13

ICPC

Hip symptom/complaint

1.3

8.5

613

4760

XX4AW

NOMESCO Finland

3.1

8.5

148

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

8.5

129

707

R4120

NOMESCO Finland

Occupational therapy

1.5

8.5

300

2059

R06AX27

ATC

desloratadine; oral

1.2

8.5

1499

12928

D01AE16

ATC

amorolfine; topical

1.4

8.5

491

3689

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.2

8.4

363

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.0

8.4

478

E83.51

ICD-10 Finland

Hypocalcemia

3.4

8.4

116

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

8.4

221

1416

9109

FHL

Other measure in this category

7.3

8.4

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

6.0

8.4

D07AB08

ATC

desonide; topical

1.4

8.4

493

3711

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.2

8.4

127

AA4BD

NOMESCO Finland

Extensive CT of sella turcica

90.1

8.4

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.2

8.4

385

AA1AA

NOMESCO Finland

Head X-ray examination

2.8

8.4

177

TPH00

NOMESCO Finland

Phlebotomy

4.0

8.4

WVA30

SPAT

1.9

8.4

124

671

S76

ICPC

Skin infection other

1.6

8.4

216

1378

N05AB04

ATC

prochlorperazine; systemic, rectal

2.0

8.4

467

M01AG01

ATC

mefenamic acid; oral

1.9

8.4

122

657

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.0

8.4

155

S19

ICPC

Skin injury other

1.7

8.4

166

985

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

8.4

105

534

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.2

8.4

133

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.2

8.4

378

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.4

8.4

340

2401

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

8.3

114

602

N05AF05

ATC

zuclopenthixol; systemic

2.6

8.3

217

SPAT1284

SPAT

Extensive health certificate

1.8

8.3

135

753

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

8.3

1693

14787

KFH00

NOMESCO Finland

Operation for undescended or ectopic testis

4.8

8.3

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

6.7

8.3

Z56.5

ICD-10 Finland

Uncongenial work

6.7

8.3

D352, E220

ICD-10 Finland

+∞

8.3

H01AX01

ATC

pegvisomant; parenteral

+∞

8.3

2554X

ICD-9 Finland

Disorders of adrenal glands, Corticoadrenal insufficiency[HYPOFUNCTIO CORTICOADRENALIS ALIA]

+∞

8.3

E2300, D352

ICD-10 Finland

+∞

8.3

2552A

ICD-9 Finland

Disorders of adrenal glands, Adrenogenital disorders[SYNDROMA ADRENOGENITALE CONGENITUM]

+∞

8.3

2538X

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin[MORBUS HYPOPHYSEOS SEU HYPOTHALAMI ALIA]

+∞

8.3

E89.3

ICD-10 Finland

Postprocedural hypopituitarism

+∞

8.3

E24.1

ICD-10 Finland

Nelson syndrome

+∞

8.3

C04AX02

ATC

phenoxybenzamine; oral

+∞

8.3

2549

FHL

+∞

8.3

E22

ICD-10 Finland

Hyperfunction of pituitary gland

+∞

8.3

Q87.16

ICD-10 Finland

Mulibrey nanism

+∞

8.3

M35.7

ICD-10 Finland

Hypermobility syndrome

2.3

8.3

307

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

8.3

516

3917

J20

ICD-10 Finland

Acute bronchitis

1.4

8.3

432

3185

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.0

8.3

N01

ICPC

Headache

1.3

8.3

591

4579

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.3

8.3

327

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.3

8.3

123

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

8.3

353

2512

Z50.5

ICD-10 Finland

Speech therapy

2.0

8.3

488

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

5.0

8.3

K11.2

ICD-10 Finland

Sialoadenitis

1.8

8.3

137

772

SFA00

NOMESCO Finland

Small filling

1.3

8.3

602

4679

N18.0

ICD-10 Finland

End-stage renal disease

2.5

8.3

233

160

Kela drug reimbursment

exenatide

2.1

8.3

405

JN3BG

NOMESCO Finland

MRI examination of abdomen with high intensity magnet

6.2

8.3

SBA00

NOMESCO Finland

Microbiological examinations

1.9

8.3

123

667

G50.1

ICD-10 Finland

Atypical facial pain

2.2

8.3

372

N03AB02

ATC

phenytoin; systemic

2.6

8.3

209

SPAT1059

SPAT

Spirometry at the office

1.6

8.3

218

1401

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

8.2

507

3846

X57

ICD-10 Finland

Unspecified privation

2.0

8.2

104

531

G04BD08

ATC

solifenacin; oral

1.5

8.2

248

1643

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

8.2

204

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

8.2

254

1696

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.8

8.2

128

706

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.1

8.2

435

F05.9

ICD-10 Finland

Delirium, unspecified

2.2

8.1

344

F22.0

ICD-10 Finland

Delusional disorder

2.3

8.1

324

R81

ICPC

Pneumonia

1.8

8.1

132

740

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.4

8.1

109

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.5

8.1

104

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.1

1732

15190

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

5.6

8.1

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.0

8.1

142

B05DA

ATC

Isotonic solutions

3.1

8.1

131

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.6

8.1

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

8.1

139

794

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.2

8.1

338

K92.0

ICD-10 Finland

Haematemesis

2.0

8.1

502

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

8.1

148

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

8.1

315

2207

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.4

8.1

268

2768A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]

17.2

8.1

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

8.1

228

1490

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

8.0

1702

14914

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.3

8.0

510

3886

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

8.0

432

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

8.0

210

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

8.0

921

7588

I84.4

ICD-10 Finland

External hemorrhoids with other complications

2.4

8.0

262

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

8.0

136

772

C08DB01

ATC

diltiazem; oral

1.7

8.0

173

1056

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.3

8.0

292

F32.8

ICD-10 Finland

Other depressive episodes

2.2

8.0

341

ACC51

NOMESCO Finland

Release of median nerve

1.4

8.0

318

2236

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.0

8.0

447

N06AX17

ATC

milnacipran; oral

2.4

8.0

263

N91.0

ICD-10 Finland

Primary amenorrhoea

5.8

8.0

K08.80

ICD-10 Finland

Toothache NOS

1.4

8.0

369

2671

X78

ICD-10 Finland

Intentional self-harm by sharp object

3.0

8.0

144

F41.00

ICD-10 Finland

Moderate panic disorder

2.0

7.9

461

Z08

ICPC

Social welfare problem

2.4

7.9

256

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

7.2

7.9

J01MA06

ATC

norfloxacin; oral

1.3

7.9

583

4542

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.3

7.9

326

D06

ICPC

Abdominal pain localized other

1.4

7.9

380

2766

F32

ICD-10 Finland

Depressive episode

1.5

7.9

256

1726

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.0

7.8

443

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

2.6

7.8

207

R21

ICPC

Throat symptom/complaint

1.2

7.8

1105

9309

I50.0

ICD-10 Finland

Congestive heart failure

1.6

7.8

218

1421

RS142

NOMESCO Finland

4.5

7.8

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.2

7.8

330

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

3.9

7.8

Z01.7

ICD-10 Finland

Laboratory examination

1.3

7.8

504

3853

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.4

7.8

260

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

4.3

7.8

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

10.8

7.8

D01AC02

ATC

miconazole; topical

1.4

7.8

329

2340

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

7.8

174

1074

A10BB12

ATC

glimepiride; oral

1.5

7.8

232

1534

B01AB04

ATC

dalteparin; parenteral

1.6

7.7

190

1199

H93.1

ICD-10 Finland

Tinnitus

1.5

7.7

272

1863

WW500

NOMESCO Finland

Blood transfusion

1.6

7.7

172

1059

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.0

7.7

449

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.0

7.7

142

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.8

7.7

122

679

WVA20

SPAT

2.6

7.7

204

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.3

7.7

306

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

7.7

358

2592

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.0

7.7

455

5BA08

NOMESCO Finland

3.4

7.7

104

C09CA03

ATC

valsartan; oral

1.4

7.7

325

2315

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

4.6

7.7

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

4.6

7.7

120

Kela drug reimbursment

Hypogammaglobulinaemia

5.5

7.6

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

7.6

179

1115

SPAT1125

SPAT

Stoma care and guidance

2.4

7.6

249

N92.2

ICD-10 Finland

Excessive menstruation at puberty

3.9

7.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

7.6

691

5536

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.9

7.6

143

J01FA01

ATC

erythromycin; systemic

1.3

7.6

703

5642

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

7.6

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.2

7.6

341

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

18.3

7.6

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.1

7.6

397

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.5

7.6

224

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

1.7

7.6

134

772

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.1

7.6

376

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

7.6

132

757

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

4.2

7.6

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.4

7.5

100

B05DB

ATC

Hypertonic solutions

3.4

7.5

100

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

7.5

188

1194

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

7.5

199

1282

-56

ICPC

Dressing/pressure/compress/tamponade

2.1

7.5

356

R94.7

ICD-10 Finland

Abnormal results of other endocrine function studies

8.8

7.5

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

7.5

341

2458

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

3.9

7.5

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.7

7.5

132

761

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

5.7

7.5

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.4

7.5

253

A08

ICPC

Swelling

1.7

7.5

161

982

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.8

7.5

162

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.8

7.5

162

H04AA01

ATC

glucagon; nasal, parenteral

1.7

7.5

140

820

R03BC01

ATC

cromoglicic acid; inhalant

2.1

7.4

394

-1

SPAT

1.6

7.4

190

1214

N05BB01

ATC

hydroxyzine; systemic

1.4

7.4

284

1985

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.8

7.4

120

674

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

3.3

7.4

107

R04.2

ICD-10 Finland

Haemoptysis

1.8

7.4

125

711

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

2.6

7.4

187

G44.8

ICD-10 Finland

Other specified headache syndromes

2.3

7.4

268

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

7.4

134

780

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

5.9

7.4

D82

ICPC

Teeth/gum disease

1.2

7.3

1868

16602

M01AH05

ATC

etoricoxib; oral

1.2

7.3

3072

28355

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.7

7.3

173

RJ421

NOMESCO Finland

4.0

7.3

RJ411

NOMESCO Finland

3.5

7.3

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.2

7.3

301

H05BX01

ATC

cinacalcet; oral

3.6

7.3

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

7.3

497

3826

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.3

7.3

X58

ICD-10 Finland

Exposure to other specified factors

1.3

7.3

686

5519

N18

ICPC

Paralysis/weakness

2.1

7.3

356

1940B

ICD-9 Finland

Malignant neoplasm of other endocrine glands and related structures, Adrenal gland[NEUROBLASTOMA SUPRARENALIS]

+∞

7.3

8370/3-C74.9

ICD-O-3

Adrenal cortical carcinoma of adrenal gland, NOS

+∞

7.3

2539X

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Unspecified

+∞

7.3

2591A

ICD-9 Finland

Other endocrine disorders, Precocious sexual development and puberty, not elsewhere classified

+∞

7.3

E22.8

ICD-10 Finland

Other hyperfunction of pituitary gland

+∞

7.3

25312

ICD-8 Finland

Diseases of pituitary gland, Nanismus hypophysarius

+∞

7.3

E31.01

ICD-10 Finland

Schmidt's syndrome

+∞

7.3

8010/3-C74.9

ICD-O-3

Carcinoma, NOS, of adrenal gland, NOS

+∞

7.3

9350/1-C75.1

ICD-O-3

Craniopharyngioma, NOS, of pituitary gland

+∞

7.3

AA4WT

NOMESCO Finland

Selective blood sample from sinus petrosus inferior

10.8

7.3

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

7.3

159

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

2.5

7.3

207

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.5

7.3

207

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.0

7.3

418

MAX99

NOMESCO Finland

Assistance to normal delivery

0.7

7.3

194

2827

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.6

7.3

164

1016

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.9

7.3

525

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.3

482

3702

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

3.2

7.2

109

S51.8

ICD-10 Finland

Open wound of other parts of forearm

2.4

7.2

226

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

7.2

473

A10AA02

ATC

1.7

7.2

147

885

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.1

7.2

337

WX308

NOMESCO Finland

Sacral anesthesy

3.5

7.2

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.6

7.2

157

962

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.9

7.2

487

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

7.2

127

730

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.7

7.2

BBA20

NOMESCO Finland

Exploration of parathyroid gland

5.1

7.2

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

7.2

411

B34.9

ICD-10 Finland

Viral infection, unspecified

1.6

7.2

155

948

R05

ICPC

Cough

1.2

7.2

1093

9275

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.7

7.2

127

734

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

7.2

576

4542

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.7

7.1

171

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

7.1

112

624

XA402

NOMESCO Finland

ENMG

1.8

7.1

117

658

Q87.19

ICD-10 Finland

Congenital malformation syndromes predominantly associated with short stature

20.0

7.1

NGQ20

NOMESCO Finland

Amputation of lower leg

3.8

7.1

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.7

7.1

1410

FHL

Laparoscopy

1.8

7.1

113

628

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

2.2

7.1

320

D07XC01

ATC

betamethasone, combinations; topical

1.3

7.1

506

3923

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.0

7.1

393

2152

FHL

Extraction, big brain

6.5

7.1

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

6.5

7.1

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.5

7.1

197

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

7.1

183

1173

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

7.1

807

6643

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

7.1

186

1197

E21.2

ICD-10 Finland

Other hyperparathyroidism

4.2

7.1

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

7.1

135

799

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.2

7.1

301

SPAT1094

SPAT

Continuous Positive Airway Pressure

2.4

7.1

223

3028

Kela drug reimbursment

Mepolizumab

12.0

7.1

R06.4

ICD-10 Finland

Hyperventilation

2.0

7.1

431

XX1VW

NOMESCO Finland

Written report from radiologist

3.0

7.1

128

H01

ICPC

Ear pain/earache

1.3

7.0

550

4321

ECB00

NOMESCO Finland

Suture of gingiva

1.7

7.0

150

915

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.7

7.0

145

877

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.0

587

4653

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.0

7.0

423

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.6

7.0

181

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.6

7.0

181

N05BA02

ATC

chlordiazepoxide; systemic

1.8

7.0

103

561

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

4.7

7.0

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.6

7.0

192

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

7.0

299

2136

H50.1

ICD-10 Finland

Divergent concomitant strabismus

2.7

7.0

158

L50.9

ICD-10 Finland

Urticaria, unspecified

1.6

7.0

169

1066

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

2.4

7.0

218

I95

ICD-10 Finland

Hypotension

4.1

7.0

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.4

7.0

237

Z49.2

ICD-10 Finland

Other dialysis

2.9

7.0

138

F84.5

ICD-10 Finland

Asperger syndrome

2.9

7.0

138

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

6.9

175

1113

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

3.6

6.9

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

3.8

6.9

E87.2

ICD-10 Finland

Acidosis

3.7

6.9

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.9

382

2850

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

6.9

266

1860

XG405

NOMESCO Finland

Education on PEF monitoring

2.2

6.9

289

K80.8

ICD-10 Finland

Other cholelithiasis

2.1

6.9

331

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

6.9

355

2617

A10BX07

ATC

[U] liraglutide; parenteral

2.4

6.9

230

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.7

6.9

140

842

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

6.9

328

2388

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.9

6.9

140

H02AB02

ATC

dexamethasone; systemic

1.3

6.9

418

3166

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.7

6.9

145

882

SPAT1197

SPAT

Extensive health check-up of expecting family

0.7

6.9

326

4326

130

Kela drug reimbursment

Malignant tumour

1.4

6.9

292

2082

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.1

6.9

324

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

6.9

143

865

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

4.6

6.9

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.9

299

2144

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

6.9

176

1128

S01

ICPC

Pain/tenderness of skin

1.6

6.9

179

1151

A10BX02

ATC

repaglinide; oral

2.6

6.9

187

D21

ICPC

Swallowing problem

2.4

6.8

221

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

6.8

476

D09

ICPC

Nausea

1.5

6.8

229

1559

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

3.9

6.8

R51.81

ICD-10 Finland

Facial pain NOS

1.9

6.8

534

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

6.8

101

549

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.6

6.8

178

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.1

6.8

360

6BA02

NOMESCO Finland

3.8

6.8

HMAK

NOMESCO Finland

1.3

6.8

577

4578

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

6.8

166

1049

C07AB03

ATC

atenolol; systemic

1.5

6.8

197

1295

WF099

NOMESCO Finland

Other radiotherapy

3.3

6.8

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

3.0

6.8

120

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

6.8

249

1725

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

6.8

326

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

8.2

6.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.9

6.8

479

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.1

6.8

339

R49.01

ICD-10 Finland

Functional dysphonia

1.7

6.8

125

729

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

6.8

120

694

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.5

6.8

189

G40

ICD-10 Finland

Epilepsy

2.6

6.8

172

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

6.8

132

783

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.8

114

647

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

10.9

6.8

C02CA01

ATC

prazosin; oral

2.3

6.8

264

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.3

6.8

264

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

6.8

107

598

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

5.0

6.8

N07BB01

ATC

disulfiram; oral

1.5

6.8

198

1308

M03AX01

ATC

botulinum toxin; parenteral

2.3

6.7

266

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.9

6.7

497

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1907

427

59.52

307.65

3.1

2.0

19.3

20.8

nmol/l

2.00

1850

410

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

652

152

46.85

307.65

1.8

1.2

1120.9

363.6

mu/l

3.85

628

144

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

963

1247

8.71

307.65

3.1

1.8

174.6

201.7

pmol/l

7.48

931

1172

(3021387) Prolactin [Units/volume] in Serum or Plasma

2332

2482

13.18

307.65

3.7

1.3

434.2

292.0

mu/l

11.28

2243

2223

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

658

157

45.82

307.65

1.8

1.2

74.1

71.6

1.34

634

149

(3008295) Osmolality of Serum or Plasma

488

576

8.99

307.65

2.3

1.3

282.9

281.6

mosm/kgh2o

0.43

422

453

(3035637) Corticotropin [Mass/volume] in Plasma

1326

717

22.24

307.65

2.3

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2058

4433

6.02

307.65

5.3

2.0

11.2

12.7

nmol/l

11.83

1904

3903

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4540

28066

2.56

307.65

10.1

6.9

1.2

mmol/l

0.37

3740

23916

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

843

143

66.25

307.65

3.4

2.4

1.1

1.6

ug/l

1.94

791

136

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

688

1061

7.03

307.65

1.8

1.4

0.3

0.4

nmol/l

3.79

504

839

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

847

789

11.97

307.65

3.1

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1331

3830

4.01

307.65

3.3

4.4

4.5

pmol/l

6.90

1217

3416

(3009214) Lutropin [Units/volume] in Serum or Plasma

1858

2094

11.46

307.65

2.1

1.4

7.6

9.4

u/l

4.98

1482

1634

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3870

5416

13.70

307.65

4.7

2.0

322.8

373.1

nmol/l

25.57

3666

4984

(43055514) Macroprolactin [Presence] in Serum or Plasma

524

117

48.04

307.65

1.7

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1352

3568

4.40

307.65

1.9

1.4

17.3

26.2

iu/l

20.36

1105

2987

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1139

1813

7.22

307.65

3.0

1.7

34.6

40.4

nmol/l

8.24

1096

1767

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

325

263

12.86

307.65

2.5

1.5

4.5

5.4

nmol/l

0.17

277

201

(3011985) Renin [Units/volume] in Plasma

636

716

9.61

307.65

3.4

1.3

78.3

60.1

mu/l

1.09

594

631

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

398

59.10

307.65

2.0

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4174

25527

2.43

301.12

9.5

6.3

1.2

mmol/l

0.76

3916

23318

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6344

47437

3.19

297.82

6.9

3.9

14.8

14.6

pmol/l

6.42

6051

43552

(3030313) Adrenal Ab [Titer] in Serum

177

34.16

278.78

1.2

—

(3003181) Sodium [Moles/volume] in Urine

504

891

5.99

273.23

2.0

1.4

76.0

65.2

mmol/l

4.39

439

721

(3018418) pH of Serum or Plasma

2970

16278

2.36

265.99

5.8

4.0

7.4

0.36

828

3094

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

411

613

7.03

263.16

1.7

1.3

29.6

36.4

nmol/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

334

401

8.67

257.94

1.9

1.3

4.2

5.0

umol/l

2.23

302

366

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

509

1029

5.23

238.00

1.9

1.3

17.1

24.7

u/l

6.29

431

858

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3838

24565

2.15

223.41

3.3

2.3

76.7

75.5

nmol/l

2.06

3567

22464

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

393

703

5.84

209.78

1.4

1.3

309.4

296.3

pmol/l

0.24

306

546

(3013826) Glucose [Moles/volume] in Serum or Plasma

4811

34227

2.13

204.34

7.2

4.7

6.6

mmol/l

0.58

4579

31782

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1638

7636

2.46

202.68

7.4

6.8

1.1

mmol/l

1.12

1556

7154

(3024561) Albumin [Mass/volume] in Serum or Plasma

3724

24196

2.07

200.93

6.4

5.0

35.4

36.0

g/l

9.72

3513

22556

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

400

757

5.52

200.90

2.2

1.2

1.1

0.6

nmol/l

0.66

389

730

(3026782) Osmolality of Urine

2153

11348

2.26

200.35

3.8

2.7

517.6

553.0

mosm/kgh2o

10.32

1908

9688

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

396

771

5.36

192.67

2.2

1.2

0.4

0.3

nmol/l

0.16

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

370

689

5.59

189.01

2.2

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5740

44775

2.20

177.51

10.0

7.2

80.9

79.1

u/l

1.37

5508

42260

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6681

55989

2.77

169.55

7.4

4.6

1.8

2.1

mu/l

3.40

6316

51944

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1061

4408

2.64

164.56

5.6

3.8

1.2

mmol/l

2.51

990

3849

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1743

9122

2.19

159.88

4.8

4.1

0.8

mmol/l

0.23

1641

8548

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4133

29569

1.88

151.57

7.5

6.1

10.5

11.4

umol/l

3.45

3919

27961

(3023368) Bacteria identified in Blood by Culture

2402

14498

1.96

147.50

5.9

4.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1499

7623

2.21

146.27

3.1

2.6

22.7

23.1

0.40

1289

6596

(3006315) Basophils [#/volume] in Blood

4250

30950

1.86

144.43

8.1

6.3

0.0

e9/l

0.12

3815

26805

(3001604) Monocytes [#/volume] in Blood

4238

30844

1.86

144.20

8.1

6.3

0.6

e9/l

8.25

3808

26726

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1577

8233

2.16

143.73

2.9

2.5

2.4

g/l

0.14

1468

7653

(3013115) Eosinophils [#/volume] in Blood

4353

32007

1.86

142.67

8.5

6.6

0.2

e9/l

0.35

3942

28215

(3015377) Calcium [Moles/volume] in Serum or Plasma

2894

18759

1.88

141.91

3.9

3.3

2.3

2.4

mmol/l

4.52

2587

16548

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2636

16605

1.90

141.04

2.8

2.2

240.3

226.2

u/l

0.09

2502

15628

(42870588) Differential panel, method unspecified - Blood

3144

20955

1.86

140.89

8.0

6.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2390

14583

1.94

140.82

2.7

2.3

3.0

2.9

mg/l

1.99

2120

12554

(3019198) Lymphocytes [#/volume] in Blood

4320

31840

1.84

138.85

8.2

6.3

2.0

e9/l

0.06

3928

28160

(3022948) Iron [Moles/volume] in Serum or Plasma

1655

8974

2.08

135.62

3.0

2.5

13.0

13.5

umol/l

1.89

1551

8382

(3022096) Basophils/100 leukocytes in Blood

3918

28177

1.82

134.98

8.5

6.5

0.6

0.7

4.79

3740

26410

(3013650) Neutrophils [#/volume] in Blood by Automated count

4658

35351

1.84

133.74

11.8

9.3

4.3

4.0

e9/l

13.06

4232

30819

(3019069) Monocytes/100 leukocytes in Blood

4021

29212

1.81

133.25

8.7

6.7

8.5

0.16

3848

27498

(3006504) Eosinophils/100 leukocytes in Blood

4003

29055

1.81

132.93

8.4

6.4

2.8

2.9

2.38

3814

27194

(3027801) Oxygen [Partial pressure] in Arterial blood

1219

5937

2.26

130.93

8.1

7.7

13.0

12.7

kpa

0.77

1158

5667

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1219

5938

2.26

130.88

8.1

7.7

5.1

kpa

0.55

1164

5669

(37021550) Renin [Units/volume] in Plasma --upright

128

104

12.50

129.98

2.1

1.2

94.5

51.9

mu/l

1.62

115

(3003396) Base excess in Arterial blood by calculation

1213

5918

2.25

129.64

8.1

7.7

0.9

1.0

mmol/l

0.21

960

4601

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3842

27735

1.79

128.11

3.7

2.9

120.3

110.0

ug/l

1.90

3613

25964

(3032080) INR in Blood by Coagulation assay

3162

21581

1.80

127.29

10.2

8.1

1.2

inr

1.31

1160

6362

(3002030) Lymphocytes/100 leukocytes in Blood

4091

30195

1.78

125.32

8.5

6.5

28.4

29.1

3.07

3904

28286

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2733

17926

1.82

124.99

3.3

2.6

56.7

57.8

u/l

0.22

2537

16592

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

222

378

6.02

124.32

1.5

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5502

44501

1.89

122.79

5.5

4.0

12.0

11.0

mm/h

6.03

5203

41517

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

947

4269

2.39

121.22

9.4

8.8

24.7

24.8

mmol/l

0.64

940

4249

(3018010) Neutrophils/100 leukocytes in Blood

4020

29752

1.76

119.74

8.1

6.3

56.9

56.3

2.68

3848

27975

(3005719) IgG [Mass/volume] in Serum or Plasma

1036

4882

2.30

119.63

3.2

2.8

9.9

10.4

g/l

2.82

910

4512

(3016038) Potassium [Moles/volume] in Urine

215

370

5.95

119.07

1.7

1.4

34.4

36.8

mmol/l

0.55

192

332

(3021589) Normoblasts [#/volume] in Blood

3782

27552

1.75

118.73

14.8

9.3

0.0

e9/l

0.47

3269

22416

(3017181) Myelocytes/100 leukocytes in Blood

1034

4887

2.29

118.50

5.1

4.3

0.9

0.05

347

1304

(3021440) Promyelocytes/100 leukocytes in Blood

985

4655

2.28

112.55

5.2

4.3

0.1

1.27

329

1201

(3002179) Metamyelocytes/100 leukocytes in Blood

954

4483

2.29

110.36

4.8

4.1

0.5

0.6

0.35

271

940

(3025159) Blasts/100 leukocytes in Blood

942

4418

2.29

109.42

5.3

4.4

0.0

0.2

1.11

292

1005

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2180

13879

1.80

106.35

3.4

3.1

1357.0

1280.4

ng/l

0.20

1855

11722

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3130

22103

1.71

105.82

2.1

1.9

97.1

96.5

pmol/l

0.27

1701

11653

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1543

8838

1.94

105.00

2.3

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2924

20301

1.72

104.95

4.7

3.3

33.1

73.6

ng/l

0.94

2054

12477

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

258

592

4.47

102.78

3.8

3.0

6.1

14.7

nmol/l

0.44

247

572

(3014576) Chloride [Moles/volume] in Serum or Plasma

1256

6748

2.03

102.51

8.3

7.3

104.1

104.6

mmol/l

2.16

1231

6606

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

886

4181

2.27

100.98

4.6

4.4

87.2

85.8

ng/l

0.13

764

3668

(1616796) Gas panel - Central venous blood

393

1246

3.27

98.28

5.2

3.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6196

53367

1.92

97.56

6.9

5.2

39.8

39.1

mmol/mol

7.04

5883

49897

(3016502) Oxygen saturation in Arterial blood

1033

5269

2.11

96.58

8.8

8.2

95.8

95.9

0.25

996

5073

(3024980) IgG subclass 4 [Mass/volume] in Serum

352

1054

3.45

96.42

1.6

1.7

0.7

0.8

g/l

1.00

203

828

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

111

114

9.86

96.28

3.2

1.6

5.1

4.2

nmol/l

0.70

106

107

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

145

213

6.92

93.72

1.6

1.5

13.7

15.0

pmol/l

1.45

130

180

(3010421) pH of Blood

429

1484

3.00

92.42

5.6

4.3

7.4

0.28

381

1249

(3012501) Base excess in Blood by calculation

388

1268

3.17

92.20

5.7

4.4

2.6

2.4

mmol/l

0.38

289

848

(3013290) Carbon dioxide [Partial pressure] in Blood

388

1269

3.17

92.08

5.7

4.4

5.0

kpa

0.34

381

1250

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

831

3967

2.23

91.65

2.1

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

388

1276

3.15

91.22

5.7

4.3

8.6

8.7

kpa

0.69

381

1256

(40767503) Oxygen content in Capillary blood by calculation

366

1163

3.26

91.12

3.4

2.5

16.4

16.7

0.48

190

590

(3019550) Sodium [Moles/volume] in Serum or Plasma

6855

61695

2.29

88.71

26.6

14.2

139.4

139.6

mmol/l

10.97

6763

60134

(3001556) Androgen free Index in Serum or Plasma

12.38

88.03

2.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2111

13941

1.71

87.33

6.5

4.5

—

(4062490)

260

680

3.92

86.95

1.6

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1560

9477

1.81

86.18

2.0

1.7

1270.2

1164.8

nmol/l

4.08

1224

7243

(3023103) Potassium [Moles/volume] in Serum or Plasma

6861

61899

2.27

86.07

26.6

14.3

3.9

4.0

mmol/l

3.71

6758

60197

(3002582) Erythrocytes [#/volume] in Urine

2540

17689

1.66

85.55

4.4

3.2

50.0

87.5

e6/l

1.86

2092

13491

(3020779) Urea [Moles/volume] in Serum or Plasma

984

5163

2.04

84.51

10.1

8.5

8.6

8.8

mmol/l

0.39

945

4963

(3024139) IgG subclass 3 [Mass/volume] in Serum

256

683

3.84

83.22

1.5

1.4

0.4

g/l

0.33

125

507

(3027135) IgG subclass 1 [Mass/volume] in Serum

256

683

3.84

83.22

1.5

1.4

6.2

6.7

g/l

1.35

127

505

(3028192) IgG subclass 2 [Mass/volume] in Serum

256

684

3.84

83.05

1.5

1.4

2.5

2.8

g/l

1.69

126

508

(3000850) Epithelial cells [#/volume] in Urine

1886

12249

1.72

82.04

3.6

2.6

5.6

6.0

e6/l

0.92

1700

10710

(3021960) Folate [Moles/volume] in Serum or Plasma

1883

12230

1.72

81.87

1.7

1.5

19.9

20.4

nmol/l

0.69

1678

10598

(3030467) Casts [#/volume] in Urine by Automated count

2351

16239

1.65

80.71

4.2

3.1

0.4

e6/l

0.03

1914

12139

(3002173) Hemoglobin [Mass/volume] in Arterial blood

931

4870

2.04

80.39

9.4

8.4

123.7

122.2

g/l

1.22

899

4693

(3007164) IgA [Mass/volume] in Serum or Plasma

2016

13396

1.69

80.28

1.7

1.5

2.3

g/l

0.60

1286

8172

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2775

20049

1.61

78.98

4.0

3.3

33.5

34.3

u/l

0.21

2628

19076

(3019060) Gas panel - Arterial blood

697

3308

2.22

77.42

6.4

4.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

803

4030

2.11

77.37

6.0

4.8

1.8

1.6

mmol/l

1.36

618

2965

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

824

4180

2.09

77.16

6.1

4.8

5.2

5.1

kpa

0.34

787

3916

(3027945) Reticulocytes/100 erythrocytes in Blood

1093

6128

1.92

77.02

3.2

3.0

1.8

1.7

1.94

956

5476

(3009343) pH of Capillary blood

817

4139

2.09

76.76

6.1

4.8

7.4

0.48

145

434

(3028026) IgM [Mass/volume] in Serum or Plasma

766

3802

2.13

75.91

2.0

1.9

1.2

1.3

g/l

0.55

719

3523

(4035726)

915

4860

2.00

75.43

1.5

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2191

15075

1.64

75.30

1.5

1.4

1.2

1.9

u/ml

3.07

637

3966

(3031040) Bacteria [#/volume] in Urine by Automated count

4744

39055

1.58

75.16

6.0

4.2

932.2

1333.6

e6/l

0.32

498

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1011

5592

1.93

73.99

4.6

3.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

286

890

3.30

73.56

2.6

1.9

1.7

mmol/l

0.45

278

870

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

612

2810

2.28

73.52

8.7

10.3

24.1

24.3

mmol/l

0.82

578

2638

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

867

4572

2.01

72.79

1.3

1.2

115.4

151.5

iu/ml

1.93

313

1688

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

118

185

6.46

71.72

2.3

1.6

0.1

0.2

nmol/l

1.10

131

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

312

1044

3.07

71.06

4.4

3.2

—

(36304419) Bacteria [Presence] in Urine

2276

15995

1.61

70.86

4.2

3.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1015

5701

1.90

70.69

7.3

5.0

5.9

5.8

kpa

0.83

984

5535

(3026008) Bacteria identified in Urine by Culture

2330

16482

1.60

70.50

3.9

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1060

6052

1.87

70.13

2.2

1.7

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

11.14

70.03

3.4

2.0

22.5

1.9

nmol/l

2.00

(3035350) Ketones [Presence] in Urine by Test strip

3729

29354

1.54

69.93

4.7

3.4

0.0

estimate

1.28

1002

5436

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1744

11506

1.67

69.76

1.8

1.6

23498452.9

28708315.1

pmol/l

0.15

1498

9736

(3023520) Reticulocytes [#/volume] in Blood

841

4460

2.00

69.31

2.7

2.8

73.2

69.4

e9/l

2.13

634

3285

(3037467) Urinalysis macro (dipstick) panel - Urine

4928

41298

1.56

68.91

5.8

4.1

—

(40761536) Microorganisms panel - Urine sediment

933

5140

1.93

68.78

5.5

3.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1062

6102

1.86

68.77

2.3

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

3761

29734

1.53

68.62

4.7

3.5

0.0

estimate

0.79

993

5441

(3012544) pH of Venous blood

1028

5862

1.87

68.14

7.2

4.9

7.4

0.09

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

547

2478

2.30

67.69

2.0

1.9

39.0

39.5

u/l

0.19

501

2236

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1057

6096

1.85

67.55

4.1

4.4

244.9

244.2

u/l

0.03

999

5787

(3037522) Nuclear Ab [Titer] in Serum

1379

8616

1.73

67.19

1.5

1.4

526.3

534.7

titre

0.06

285

1708

(3002032) Base excess in Venous blood by calculation

1001

5684

1.88

67.17

7.4

5.0

1.9

1.8

mmol/l

0.56

842

4618

(3021601) Nitrite [Presence] in Urine by Test strip

3720

29427

1.52

67.08

6.2

4.7

0.0

estimate

0.59

1021

5581

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

345

1264

2.81

66.69

4.2

3.7

58.6

56.8

1.64

345

1264

(3000991) Gas panel - Venous blood

932

5183

1.91

66.66

10.4

9.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1393

8758

1.72

66.27

2.5

29.6

29.8

0.61

1349

8517

(3022806) Fractional oxyhemoglobin in Capillary blood

243

732

3.40

65.82

2.4

1.8

89.3

90.2

1.25

235

720

(3020630) Protein [Mass/volume] in Serum or Plasma

797

4220

1.99

65.81

2.8

2.5

65.7

66.7

g/l

3.04

741

3882

(3018095) Leukocytes [#/volume] in Urine

2807

20964

1.54

65.76

5.0

3.7

63.1

87.9

e6/l

1.90

2189

14586

(3029937) Albumin [Presence] in Urine by Test strip

2193

15519

1.58

65.16

5.1

3.8

0.0

estimate

0.31

995

5391

(3013512) EKG study

2159

15233

1.58

64.93

4.3

3.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

965

5506

1.86

63.55

2.7

2.5

0.2

g/l

0.63

900

5166

(3007853) Bacteria identified in Skin by Aerobe culture

1163

7050

1.77

62.61

2.3

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

878

4899

1.90

61.89

9.1

7.8

1.3

mmol/l

0.32

839

4690

(3008152) Bicarbonate [Moles/volume] in Arterial blood

633

3169

2.09

60.82

9.1

6.8

24.7

24.5

mmol/l

0.82

591

2941

(3024354) Oxygen [Partial pressure] in Venous blood

860

4808

1.89

60.16

6.8

4.6

4.8

kpa

1.55

832

4659

(3016244) Insulin [Units/volume] in Serum or Plasma

200

564

3.61

59.95

2.3

3.5

21.2

27.1

mu/l

1.47

189

536

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

380

1548

2.53

59.42

2.0

9.0

11.0

mg/l

4.35

353

1446

(3021901) Oxygen saturation in Capillary blood

283

992

2.92

59.32

3.9

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1909

13334

1.58

58.89

2.2

1.9

1.1

mg/l

0.20

1464

10023

(3009508) Creatinine [Moles/volume] in Urine

2376

17436

1.53

58.67

4.0

3.3

7.6

7.8

mmol/l

1.10

2051

14907

(3042936) Bacteria identified in Isolate by Culture

1269

8022

1.70

58.40

2.6

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2246

16296

1.54

58.38

4.6

3.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

646

3307

2.04

58.35

2.5

2.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

356

1425

2.57

57.73

4.1

4.3

24.7

24.6

mmol/l

0.11

333

1254

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2944

22699

1.49

56.79

5.0

3.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

385

1627

2.44

55.61

1.4

1.7

513.5

500.1

mg/l

0.21

364

1548

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

635

3322

1.99

53.84

9.5

9.7

1.4

0.00

630

3301

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6201

55879

1.63

53.83

19.5

11.6

84.6

85.6

ml/min/173m2

2.52

5479

45690

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

194

578

3.42

53.47

1.7

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

501

2417

2.15

52.84

1.5

6.8

14.9

u/ml

1.26

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

350

1452

2.48

52.60

1.4

1.7

3.7

mmol/l

0.13

320

1363

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6716

61930

1.81

52.17

22.2

12.8

20.8

22.5

mg/l

5.22

5697

48158

(3044290) Cell count panel - Cerebral spinal fluid

333

1355

2.52

52.15

1.5

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6290

57003

1.64

51.94

5.2

4.1

5.9

5.8

mmol/l

1.92

5913

52590

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

429

1967

2.25

51.32

2.6

2.0

1.8

2.3

ug/l

0.53

388

1748

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

348

1462

2.45

50.88

1.6

1.8

917.6

3984.8

e6/l

0.63

284

1173

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

348

1462

2.45

50.88

1.5

1.8

57.5

22.9

e6/l

0.47

268

1110

(3015171) Extractable nuclear Ab [Units/volume] in Serum

492

2405

2.12

50.10

1.3

0.7

1.0

u/ml

0.26

214

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1425

9633

1.59

49.34

3.4

2.9

2.4

mmol/l

0.07

1249

8384

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

424

1966

2.22

49.34

8.4

7.7

1.5

1.3

mg/l

2.71

396

1862

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

360

1564

2.37

48.83

1.5

1.3

—

(3044889) 12 lead EKG panel

4687

40193

1.44

48.15

4.3

3.4

—

(40768797) Stomach Pathology biopsy report

1203

7849

1.63

48.10

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

373

1662

2.31

47.72

2.2

1.7

—

(3012516) Albumin [Mass/volume] in Urine

2064

15228

1.49

47.51

3.6

3.3

540.9

380.1

mg/l

0.68

1384

9718

(3036603) Volume of Urine

136

347

3.97

47.11

1.6

1.5

1798.5

1953.8

0.35

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2089

15475

1.48

47.03

5.1

4.4

2.4

2.8

ug/l

0.23

1899

14003

(3027273) Bicarbonate [Moles/volume] in Venous blood

491

2462

2.06

46.67

5.2

3.7

25.0

25.3

mmol/l

0.86

469

2378

(3018405) Lactate [Moles/volume] in Arterial blood

390

1789

2.24

46.55

4.5

3.8

1.4

mmol/l

0.01

381

1761

(3025941) Bacteria identified in Stool by Culture

644

3568

1.88

45.79

1.4

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

747

4343

1.80

45.45

1.7

1.3

319.9

224.5

u/ml

0.71

702

4041

(3020891) Body temperature

430

2075

2.14

45.21

5.7

4.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

200

4.95

45.08

1.9

2.6

120.1

130.4

ng/l

0.21

135

(3004119) Hemoglobin [Mass/volume] in Venous blood

596

3238

1.91

44.99

6.7

4.0

130.4

129.7

g/l

0.28

579

3156

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

325

1401

2.38

44.85

2.1

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

2047

15234

1.47

44.55

5.0

4.2

92.9

91.5

1.57

1994

14862

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

327

1420

2.36

44.38

2.0

1.7

—

(40761511) CBC panel - Blood by Automated count

6901

64640

1.84

44.23

21.3

11.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

454

2255

2.08

44.23

5.5

4.2

47.5

49.7

1.12

446

2225

(3046904) Somatotropin [Units/volume] in Serum or Plasma

96.59

43.78

3.3

1.2

1.8

4.0

mu/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

592

3238

1.90

43.74

1.7

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

396

1875

2.17

43.68

2.4

413.4

609.6

ug/l

0.71

370

1749

(3020682) Albumin/Creatinine [Ratio] in Urine

2123

15967

1.46

43.55

4.4

4.0

10.9

10.8

mg/mmol

0.03

1409

10260

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

226

829

2.78

43.55

1.9

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

299

1262

2.42

43.24

2.9

3.0

33.1

35.0

umol/l

0.66

245

1092

(3044640) Blood type and Crossmatch panel - Blood

2421

18705

1.43

42.83

3.0

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4816

41907

1.42

42.73

4.3

3.1

53.1

44.7

u/l

6.64

4555

39502

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

8.88

42.72

3.5

2.5

106.6

71.2

pmol/l

0.30

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

415

3.54

42.57

1.9

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

232

873

2.71

42.57

1.5

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

123

6.06

42.52

1.5

1.6

0.4

ug/l

0.24

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

162

500

3.29

42.26

1.7

1.3

69.1

133.0

pmol/l

0.51

151

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

404

1953

2.13

42.25

1.8

1.6

144.2

375.8

titre

2.14

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

255

1018

2.56

41.54

1.4

3.8

4.6

ug/l

0.52

229

915

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6915

64989

1.82

41.30

25.3

14.3

78.5

74.4

umol/l

13.12

6910

64965

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

184

625

2.99

40.83

1.8

2.3

32.1

32.6

0.77

184

619

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

257

1039

2.52

40.78

1.3

1.2

46.7

230.5

titre

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

355

1660

2.19

40.39

1.5

1.4

264.1

288.4

ug/g

1.40

208

931

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1995

15002

1.45

40.36

1.7

1.6

1.5

1.4

mmol/l

8.24

1715

12800

(3002385) Erythrocyte distribution width [Ratio]

5815

52595

1.47

40.03

26.1

15.6

13.7

13.6

13.25

5741

51530

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

415

2075

2.06

39.66

7.6

5.2

1.6

1.7

1.59

389

1939

(3026493) Urate [Moles/volume] in Serum or Plasma

1965

14791

1.44

39.36

3.0

2.6

2287.7

3928.4

umol/l

1.78

1714

13016

(3048689) Calprotectin [Mass/mass] in Stool

1221

8363

1.55

38.92

2.5

141.9

122.9

ug/g

0.84

980

6673

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

124

5.77

38.80

1.2

310.9

265.1

pmol/l

0.39

(3042631) Mycobacterium sp identified in Specimen

186

662

2.85

37.96

3.1

2.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

249

1028

2.47

37.79

2.0

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

293

1309

2.29

37.22

6.6

6.5

541.5

1871.7

iu/ml

0.55

185

(3022313) Gas panel - Capillary blood

558

3151

1.83

37.13

6.6

5.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

460

2444

1.94

36.97

5.9

3.7

0.7

0.22

449

2347

(3028626) Oxygen [Partial pressure] in Capillary blood

410

2094

2.01

36.93

7.6

5.5

9.0

9.1

kpa

0.45

397

1969

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3361

27952

1.37

36.68

4.9

4.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

403

2061

2.01

36.15

7.7

5.3

0.9

1.21

377

1933

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

383

1924

2.04

36.11

1.7

0.2

g/l

0.23

363

1826

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

188

693

2.76

35.93

1.9

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

190

709

2.72

35.47

1.9

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

277

1240

2.28

35.03

3.1

2.2

128.3

131.0

g/l

1.00

228

906

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

149

491

3.07

34.90

1.3

2.1

2.0

mmol/l

0.46

134

457

(40758558) Short blood count panel - Blood

2047

15800

1.41

34.81

8.4

7.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

388

1985

2.01

34.76

1.7

1.2

g/l

1.87

371

1886

(3016018) Differential panel - Cerebral spinal fluid

191

726

2.67

34.40

1.6

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

239

1014

2.40

34.19

4.6

4.4

28077.7

1158.3

u/ml

0.46

(3011412) CD3 cells [#/volume] in Blood

188

713

2.68

34.01

2.6

2.7

1.3

1.2

e9/l

0.16

128

448

(3023419) Bacteria identified in Sputum by Culture

174

639

2.76

33.51

4.0

2.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

160

562

2.89

33.49

2.7

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

307

1460

2.15

33.46

3.7

3.3

57.2

92.8

mg/l

0.41

222

1178

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1006

6841

1.54

32.65

3.6

3.1

6.8

7.5

umol/l

0.53

838

5899

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

503

2864

1.81

32.49

12.2

10.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

297

1418

2.14

32.04

3.7

3.3

1.4

2.1

ratio

0.78

119

(3043409) Potassium [Moles/volume] in Arterial blood

311

1516

2.10

31.79

5.1

4.0

3.8

3.9

mmol/l

1.50

292

1420

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6882

65210

1.67

31.69

14.4

9.7

29.6

26.7

u/l

3.44

6731

63121

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

302

1459

2.11

31.60

3.8

3.4

29.8

56.8

mg/l

1.97

217

1178

(3004809) Band form neutrophils/100 leukocytes in Blood

212

885

2.43

31.45

3.6

3.5

1.3

1.5

0.21

174

672

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

204

840

2.47

31.18

1.9

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

137

462

3.00

30.87

1.6

1.3

0.7

u/ml

0.46

183

(3000494) Fungus identified in Specimen by Culture

1011

6972

1.52

30.61

1.8

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

161

598

2.73

30.37

2.5

75.2

71.1

2.92

153

581

(3037756) Immunofixation for Serum or Plasma

221

956

2.35

30.29

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

200

828

2.45

30.22

1.2

33.5

42.2

u/l

0.22

176

719

(3012565) Volume of 24 hour Urine

102

291

3.54

30.19

2.0

2.3

2312.4

2039.5

0.87

266

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

310

1541

2.05

30.07

1.7

1.9

34.0

4.5

iu/l

0.48

102

577

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

498

2898

1.77

29.84

7.2

5.0

24.8

24.6

mmol/l

0.87

470

2759

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

284

3.55

29.81

2.0

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

574

3480

1.70

29.72

8.5

5.6

24.3

24.0

mmol/l

1.16

532

3219

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

280

3.57

29.69

2.0

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

241

1094

2.24

29.50

3.6

3.5

—

(40768804) Tissue Pathology biopsy report

2873

23856

1.33

29.45

2.2

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

999

2.29

29.04

1.9

1.5

—

(3022145) Colonoscopy Study observation

934

6401

1.52

29.02

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

157

590

2.69

28.97

2.5

11.8

12.4

0.25

352

(3007566) Smooth muscle Ab [Titer] in Serum

336

1746

1.97

28.78

1.3

1.4

132.6

132.1

titre

0.00

163

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

323

3.31

28.34

1.9

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

289

3.42

27.60

1.8

1.7

6.1

7.0

mmol/24h

—

(3026389) Candida sp identified in Specimen by Organism specific culture

201

875

2.33

27.18

1.5

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

107

5.17

26.82

1.4

1.1

28.3

0.7

umol/24h

0.49

(3009466) Valproate [Moles/volume] in Serum or Plasma

210

938

2.27

26.75

6.5

5.1

374.8

375.6

umol/l

0.02

191

828

(3034770) Mitochondria Ab [Titer] in Serum

327

1730

1.93

26.57

1.3

955.6

965.2

titre

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1260

9322

1.42

26.23

3.7

2.9

3.4

2.7

e6/l

1.49

749

4991

(3017143) Hepatitis C virus Ab [Presence] in Serum

1121

8136

1.44

25.91

1.8

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

314

1657

1.93

25.71

3.1

2.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

103

328

3.17

25.67

1.8

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

169

700

2.45

25.56

1.2

1.1

85.4

64.3

au/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

405

2329

1.78

25.24

1.8

1.5

g/l

0.29

351

2002

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1814

14348

1.35

24.95

2.9

2.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

111

4.89

24.75

1.6

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

232

1119

2.11

24.43

1.7

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

143

562

2.57

24.19

1.2

66.1

81.0

u/l

0.62

110

386

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.36

23.93

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

188

841

2.27

23.90

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

154

636

2.45

23.48

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6051

56532

1.36

23.43

4.5

3.7

1.4

1.3

mmol/l

32.12

5657

52551

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

175

767

2.31

23.35

1.8

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

504

3153

1.64

23.04

1.9

1.6

—

(36660697) Celiac disease serology panel - Serum

805

5600

1.49

22.99

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

658

4397

1.54

22.73

2.5

2.4

27.7

22.3

au/ml

0.33

275

(3047181) Lactate [Moles/volume] in Blood

304

1658

1.87

22.53

9.2

6.0

1.3

mmol/l

0.39

265

1458

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6265

58956

1.38

22.35

5.0

4.1

4.6

4.7

mmol/l

14.65

5898

55338

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6228

58563

1.37

22.23

4.9

4.0

1.4

1.5

mmol/l

25.31

5835

54722

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1363

10485

1.37

22.08

1.4

1.3

28.6

29.3

iu/ml

0.06

378

3259

(3004451) EKG impression Narrative

240

3.36

22.01

1.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6337

59776

1.38

22.00

5.3

4.4

2.7

2.8

mmol/l

11.75

5943

55752

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

308

1700

1.85

21.99

1.4

1.3

39.5

34.2

u/ml

0.10

100

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1298

9916

1.37

21.95

3.5

2.7

1.3

1.1

e6/l

0.34

788

5554

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

251

1296

1.97

21.94

1.3

23.8

40.1

u/ml

1.64

129

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

308

3.04

21.75

1.3

56.1

67.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

608

4032

1.55

21.71

1.4

1.3

41.8

49.4

au/ml

0.35

170

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

501

3176

1.62

21.70

2.4

2.3

4597.0

6001.9

u/l

0.56

152

1207

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

166

738

2.28

21.45

7.4

6.9

11.9

11.2

mg/l

1.03

150

692

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

284

1547

1.87

21.14

1.4

1.3

2.3

6.2

u/ml

1.13

150

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

286

1568

1.86

20.87

1.4

1.3

7.9

8.5

u/ml

0.06

247

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

133

550

2.44

20.27

2.6

2.9

527.9

496.7

e6/l

0.30

107

452

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

467

2.57

20.26

1.2

—

(3019225) pH of Specimen

746

5237

1.47

20.25

5.2

4.1

—

(3023410) Appearance of Cerebral spinal fluid

161

726

2.24

20.14

1.7

2.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

101

368

2.77

19.91

1.6

1.5

6.7

6.2

u/l

0.13

316

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

128

525

2.46

19.87

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

101

369

2.76

19.81

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

143

618

2.34

19.77

4.4

4.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

147

644

2.31

19.70

7.3

15.5

7.5

7.1

mmol/l

0.57

123

542

(3039162) Centromere protein B Ab [Units/volume] in Serum

168

779

2.18

19.64

1.3

41.8

51.4

u/ml

0.21

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

238

3.21

19.56

4.8

4.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

239

1264

1.92

19.50

1.3

2.4

4.3

u/ml

0.48

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

129

538

2.42

19.33

2.6

2.9

0.2

e9/l

0.02

108

449

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

352

2.78

19.28

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1354

10602

1.34

19.23

4.5

3.5

425.8

522.9

ng/l

0.25

950

7655

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

209

1063

1.99

19.12

1.2

1.1

25.6

8965.4

iu/ml

0.57

272

(21494815) CD4 cells/100 lymphocytes in Specimen

144

634

2.29

19.09

2.4

2.7

36.2

43.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

300

1719

1.78

18.95

3.5

4.4

0.3

u/ml

0.37

182

979

(3037121) Protein [Mass/volume] in Urine

345

2058

1.71

18.91

3.9

3.8

0.3

g/l

0.93

184

988

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

325

1911

1.73

18.76

1.8

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

522

3459

1.55

18.66

1.1

1.2

119.3

218.8

titre

—

112

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

7.32

18.62

3.1

2.6

347.2

17.5

pmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1688

13698

1.30

18.45

2.0

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

616

4239

1.49

18.43

3.4

3.0

140.8

178.9

ng/l

2.28

553

3819

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

108

424

2.57

18.41

10.1

12.1

0.6

mmol/l

0.06

387

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

181

3.44

17.87

2.4

2.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

130

566

2.32

17.72

1.2

1.1

39.1

38.9

mg/l

0.02

471

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

369

2282

1.65

17.64

2.3

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

300

1756

1.74

17.62

3.4

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

873

6469

1.39

17.49

22.4

21.9

1.2

1.3

inr

0.30

119

991

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1265

9942

1.33

17.33

1.4

1.3

7.0

10.5

u/ml

1.77

499

3992

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

341

2077

1.67

17.30

2.1

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

373

2325

1.63

17.29

1.8

—

(3007461) Platelets [#/volume] in Blood

7154

69488

1.63

17.25

32.6

18.8

260.0

255.6

e9/l

6.39

7049

67752

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

315

1880

1.70

17.25

3.0

2.2

3.7

3.8

g/l

0.91

225

1366

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

315

1880

1.70

17.25

3.0

2.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

144

663

2.19

17.18

1.1

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

315

1882

1.70

17.18

3.0

2.2

7.3

7.4

g/l

0.06

230

1434

(3030981) Hyaline casts [#/volume] in Urine by Automated count

436

2835

1.57

16.95

3.4

2.7

0.3

e6/l

0.24

430

2752

(3039000) Anion gap in Blood

216

1159

1.89

16.92

11.2

7.1

11.3

mmol/l

0.06

195

1038

(3018572) Chloride [Moles/volume] in Blood

216

1160

1.89

16.87

11.2

7.1

104.6

105.2

mmol/l

0.74

195

1039

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

441

2881

1.56

16.79

1.1

12.2

u/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

108

446

2.44

16.59

2.5

3.5

100.1

95.9

0.58

103

420

(3035941) MCH [Entitic mass]

7154

69537

1.62

16.58

32.4

18.7

30.0

30.2

5.31

7102

68646

(3024731) MCV [Entitic volume]

7154

69540

1.62

16.54

32.4

18.7

90.3

90.4

0.51

7103

68650

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1524

12357

1.29

16.51

4.2

3.8

22.4

21.8

0.76

665

5457

(3026361) Erythrocytes [#/volume] in Blood

7154

69551

1.61

16.39

32.6

18.8

4.5

e12/l

0.15

7039

67649

(21494814) CD8 cells/100 lymphocytes in Specimen

233

3.02

16.33

2.2

2.1

—

(3010813) Leukocytes [#/volume] in Blood

7155

69568

1.61

16.32

32.6

18.8

7.0

6.7

e9/l

18.85

7036

67648

(3000963) Hemoglobin [Mass/volume] in Blood

7154

69568

1.61

16.16

32.8

18.9

135.2

135.9

g/l

3.68

7101

68683

(3008037) Lactate [Moles/volume] in Venous blood

199

1057

1.91

16.09

4.7

3.1

1.5

mmol/l

0.23

193

1030

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1772

1.70

16.04

3.0

2.2

3.0

3.1

g/l

0.78

230

1401

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

123

549

2.26

15.86

1.1

271.8

249.6

mg/l

0.27

479

(21494755) Public health laboratory ask at order entry panel

502

7196

0.68

15.73

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

233

1312

1.80

15.67

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.74

15.60

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

224

3.01

15.53

2.3

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

612

4354

1.44

15.38

3.2

2.3

6.0

7.3

ug/l

0.94

519

3825

(3045716) Anion gap in Serum or Plasma

236

2.94

15.37

2.3

2.4

8.9

9.2

mmol/l

0.41

177

(3006653) Thiamine [Moles/volume] in Blood

280

2.77

15.33

1.3

135.9

137.0

nmol/l

0.08

280

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

362

2.53

15.17

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

1742

1.68

15.04

3.1

2.2

9.5

10.4

g/l

2.98

246

1493

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

220

1236

1.80

14.92

1.4

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1066

8340

1.32

14.89

1.9

1.8

1.5

1.4

2.61

912

7451

(40768443) Skin Pathology biopsy report

378

2451

1.57

14.89

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

270

1610

1.70

14.87

3.2

2.2

0.5

0.9

g/l

2.04

235

1407

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

107

463

2.33

14.86

15.2

19.6

1437.7

3495.4

nmol/l

0.50

102

449

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

366

2.50

14.84

2.7

2.8

29.5

26.6

1.10

356

(3014271) Vancomycin [Susceptibility]

221

2.96

14.65

2.9

2.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

323

2029

1.62

14.54

3.7

3.5

g/l

0.00

305

1933

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

255

2.80

14.49

1.1

724.2

312.6

ng/l

0.55

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

222

1262

1.78

14.49

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

222

1262

1.78

14.49

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

220

1252

1.78

14.31

1.5

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

345

2211

1.59

14.30

2.9

3.5

94.8

92.5

1.02

323

2073

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

195

1071

1.84

14.26

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

163

845

1.95

14.22

1.5

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

706

5221

1.39

14.21

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

264

2.74

14.15

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

363

2.47

14.11

1.1

1.5

11.0

nmol/l

1.31

(3024928) Oxygen saturation in Venous blood

216

1230

1.78

14.03

8.2

4.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

389

2.41

13.97

2.8

3.0

11.7

13.0

0.44

376

(3028707) Methadone [Presence] in Urine by Screen method

248

1471

1.71

13.95

5.7

2.9

—

(4027681)

102

446

2.30

13.86

1.5

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

313

1982

1.60

13.65

3.5

3.3

177.4

181.3

0.35

302

1894

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

240

1428

1.70

13.36

3.1

2.1

0.0

g/l

1.51

226

1320

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

136

680

2.02

13.18

1.8

1.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

263

2.68

13.15

1.2

1.1

106.5

86.6

u/l

0.43

208

(3036489) Thrombin time

370

2456

1.53

13.14

2.8

2.9

21.2

21.6

0.68

319

2147

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

108

498

2.18

12.95

1.3

1.6

1.4

nmol/l

0.84

100

452

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

261

2.66

12.81

1.2

1.1

47.7

25.3

u/l

0.50

201

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.92

12.59

1.4

1.1

15.4

1.7

umol/24h

0.50

(3002256) Pathology report gross observation

944

7440

1.31

12.37

1.3

—

(3042517) Benzodiazepines panel - Urine

4.01

12.33

4.0

2.5

—

(3019150) Specific gravity of Urine by Refractometry

1525

12756

1.24

12.27

4.7

3.8

1.0

kg/l

0.65

240

1912

(3016650) Hepatitis A virus Ab [Presence] in Serum

190

1088

1.76

12.16

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

736

5616

1.34

12.10

3.0

2.5

34.7

45.5

u/l

0.64

628

4815

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

185

2.93

12.08

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

341

2.39

12.05

1.6

1.5

7.1

5.7

u/l

0.32

173

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

628

2.01

12.00

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

398

2.28

11.97

1.8

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

855

6679

1.32

11.94

9.6

6.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

121

602

2.03

11.93

1.9

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

211

1255

1.70

11.81

2.2

2.3

1.0

0.8

nmol/l

2.29

181

1065

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

210

1249

1.70

11.76

2.6

2.4

121.9

112.2

ug/min

0.08

127

780

(44790048)

141

744

1.91

11.75

2.0

1.6

—

(44806118)

141

744

1.91

11.75

2.0

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

158

3.05

11.52

2.1

2.3

15.6

16.7

umol/l

0.28

158

(3019420) Tryptase [Mass/volume] in Serum or Plasma

361

2.31

11.50

1.8

1.5

11.3

7.7

ug/l

0.38

315

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

380

2.28

11.48

1.2

1.1

u/l

0.22

176

(44790049)

140

744

1.90

11.43

2.0

1.6

—

(44790047)

140

744

1.90

11.43

2.0

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.65

11.38

3.9

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

243

2.60

11.30

2.1

2.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

114

567

2.02

11.28

3.5

2.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

461

2.14

11.24

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1104

8986

1.27

11.17

3.1

2.8

0.7

ug/l

0.10

713

5551

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1347

11218

1.24

11.16

1.8

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

258

1640

1.59

11.14

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

132

696

1.91

11.05

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

324

2.36

11.03

1.3

1.2

27.4

22.6

u/l

0.42

277

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

217

1326

1.65

10.99

3.2

2.1

0.0

g/l

0.00

204

1224

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

337

2.33

10.99

1.3

1.2

85.7

95.1

u/l

0.39

292

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

215

1311

1.66

10.98

3.2

2.1

0.0

g/l

0.00

204

1223

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

107

3.47

10.94

2.1

3.1

37.3

40.0

mg/l

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

102

495

2.07

10.80

1.9

1.5

31.5

32.9

0.13

295

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.88

10.80

5.1

6.0

60.9

43.5

ug/min

0.67

(3038515) Glucose [Moles/volume] in Venous blood

172

994

1.75

10.72

5.2

3.1

7.4

mmol/l

0.05

167

971

(3004775) Volume in Urine collected for unspecified duration

405

2.19

10.68

2.3

705.4

629.9

0.74

276

(3049717) Cytology report of Urine Cyto stain

268

1737

1.56

10.66

2.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

171

2.88

10.65

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1471

1.61

10.60

3.1

2.0

37.3

38.0

g/l

0.84

212

1283

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

224

1394

1.62

10.57

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

343

2.29

10.57

26.1

27.8

106.4

124.8

ug/l

1.68

295

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

123

645

1.92

10.49

1.9

1.6

56.0

55.6

0.04

404

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.98

10.45

1.3

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

302

2.36

10.39

1.6

1.8

1.3

nmol/l

1.69

234

(3028679) Herpes simplex virus Ab [Presence] in Serum

365

2.23

10.37

1.1

1.2

—

(4010399)

544

4059

1.37

10.34

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.13

10.28

2.0

1.7

48.2

44.7

umol/l

0.16

(40761535) Cells panel - Urine sediment

589

4454

1.35

10.26

4.3

3.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.39

10.23

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

319

2.30

10.06

2.7

3.0

270.2

234.9

e6/l

0.31

200

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

195

2.68

9.90

1.3

1.2

24.0

20.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

302

2043

1.50

9.88

1.7

1.6

0.1

3.7

iu/ml

0.69

428

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

184

2.73

9.87

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

184

2.73

9.87

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

233

1491

1.58

9.82

1.6

—

(3016750) Collection duration of Urine

304

2.31

9.79

2.3

2.2

515.9

494.0

min

0.84

229

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

148

843

1.77

9.74

2.3

3.1

104.1

563.7

u/ml

0.68

141

785

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

6.83

9.71

1.5

1.4

1.6

1.4

1.02

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

393

2806

1.42

9.71

2.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

825

6587

1.28

9.70

4.7

4.1

31.4

32.0

0.83

625

4604

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

116

615

1.90

9.61

1.4

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

182

2.70

9.52

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

323

2232

1.47

9.51

8.1

3.0

—

(3007463) Buprenorphine [Presence] in Urine

5.46

9.43

9.6

4.9

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.68

9.40

1.6

1.2

30.4

61.8

2.45

(3011397) Hemoglobin [Presence] in Urine by Test strip

1609

13862

1.20

9.36

4.2

3.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

475

2.01

9.34

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

114

607

1.89

9.34

3.8

4.7

143.4

70.4

u/ml

0.43

173

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

287

2.31

9.23

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

512

1.96

9.20

2.4

2.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

177

1080

1.65

9.09

1.1

—

(3017704) Immunofixation for Urine

258

2.37

9.09

1.7

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

594

4579

1.32

9.08

2.9

2.6

67.9

69.6

ml/min/173m2

0.44

257

1756

(3000012) Reticulocyte production index

277

2.32

9.05

1.3

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

143

2.88

8.97

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

215

1383

1.57

8.90

1.6

101.7

111.6

u/ml

0.69

250

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

201

2.55

8.84

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

325

2.19

8.81

1.5

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

251

2.36

8.69

3.3

3.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

476

1.96

8.60

2.8

2.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

382

2.08

8.54

3.3

2.7

27.8

29.4

ug/l

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

6.37

8.51

1.2

1.1

1.2

1.1

u/field

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

153

2.75

8.50

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

100

527

1.91

8.49

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

274

1887

1.47

8.26

1.1

4.7

7.2

u/ml

0.48

246

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

368

2.07

8.21

2.6

42.9

40.8

0.35

117

(1001926) Buprenorphine [Presence] in Urine by Screen method

360

2610

1.40

8.19

4.9

2.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

101

543

1.87

8.09

1.4

1.5

1.3

promille

0.01

425

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4759

45000

1.16

8.05

3.5

3.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

319

2.14

7.98

1.1

2.0

18.7

u/ml

—

(3017732) Neutrophils [#/volume] in Blood

546

4241

1.31

7.92

3.1

2.7

4.3

4.2

e9/l

0.64

416

3431

(3017354) Segmented neutrophils/100 leukocytes in Blood

533

1.87

7.91

3.7

3.4

59.9

57.5

0.45

327

(3026250) Tacrolimus [Mass/volume] in Blood

342

2.08

7.79

47.5

37.2

6.8

7.3

ug/l

1.97

316

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.20

7.70

1.8

1.2

671.3

424.0

nmol/l

0.50

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

228

2.33

7.66

1.1

100.4

88.4

2.63

110

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

319

2.11

7.59

1.5

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

157

2.62

7.58

1.4

89.3

124.9

nmol/l

1.32

117

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

261

2.23

7.56

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

191

1245

1.55

7.53

5.7

4.0

—

(3024869) Neuronal Ab [Presence] in Serum

3.22

7.49

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

119

2.86

7.45

1.8

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

496

6337

0.77

7.41

1.6

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

142

2.68

7.38

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

439

1.92

7.37

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

5.91

7.36

1.1

1.0

—

(3044927) Protein electrophoresis panel - Urine

468

1.89

7.33

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

443

1.91

7.19

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

100

3.01

7.16

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.12

7.11

2.7

2.4

1.2

umol/l

0.14

(3045142) Bone marrow Pathology biopsy report

107

611

1.76

7.10

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

249

2.22

7.09

1.5

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

269

2.16

7.05

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

218

2.30

7.04

1.3

1.2

114.7

109.2

0.85

193

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

123

2.77

7.03

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

118

696

1.71

6.99

1.7

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

534

1.81

6.96

2.5

2.8

651.7

717.8

e6/l

0.46

177

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.15

6.96

2.0

1.6

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

3.3

2.7

mg/l

0.15

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

1.7

1.5

mg/l

0.10

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

1.7

2.5

mg/l

0.33

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

0.5

1.4

mg/l

1.90

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

3.6

4.3

mg/l

0.21

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

3.6

4.6

mg/l

0.35

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

1.9

1.4

mg/l

0.22

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

1.1

1.6

mg/l

0.49

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.29

6.94

1.8

0.9

mg/l

0.02

(3045424) Erythrocytes [Presence] in Urine

154

976

1.59

6.89

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

298

2.09

6.89

2.5

2.4

199.6

179.5

umol/l

0.10

162

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

136

838

1.63

6.83

1.2

1.1

1.6

1.5

g/l

0.99

127

756

(3034891) Synovial lining cells/100 cells in Synovial fluid

260

2.16

6.80

1.9

1.4

1.7

4.0

1.42

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

117

694

1.70

6.80

1.7

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

517

1.81

6.77

1.1

1.0

308.9

286.4

mg/l

1.76

468

(3048929) Epstein Barr virus Ab [Presence] in Serum

347

2586

1.36

6.73

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

229

2.23

6.73

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.21

6.67

1.8

1.2

1.1

mg/l

0.08

(3052592) Norovirus Ag [Presence] in Stool

2.98

6.63

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.98

6.63

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

116

692

1.69

6.62

1.7

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

151

963

1.58

6.60

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

356

2673

1.35

6.58

4.5

3.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

119

716

1.67

6.58

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

219

2.24

6.54

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

213

2.26

6.52

1.3

—

(4306422)

156

1006

1.56

6.51

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

117

703

1.67

6.50

1.7

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

117

704

1.67

6.47

1.7

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

326

2.00

6.47

2.9

2.4

60.7

52.9

umol/l

0.86

284

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

155

1000

1.56

6.46

1.3

8.6

4.0

u/ml

1.32

429

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

241

2.16

6.37

1.3

1.2

0.3

g/l

1.58

196

(3019977) pH of Arterial blood

275

2.08

6.31

2.5

3.1

7.4

0.15

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

150

967

1.56

6.28

1.2

1.1

122.5

115.9

1.61

135

877

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

250

1789

1.41

6.23

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

446

1.82

6.13

1.5

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

490

1.78

6.11

4.1

3.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

251

1806

1.40

6.07

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

253

2.10

6.05

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

221

2.18

6.00

1.0

1.2

106.5

85.7

2.38

108

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

450

1.81

5.96

1.5

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

400

1.86

5.95

1.1

1.2

1.1

ratio

0.46

145

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

123

2.61

5.94

1.6

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

156

1029

1.53

5.92

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

5.87

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

217

2.17

5.84

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.78

5.80

1.3

1.1

—

(4198724)

404

1.84

5.77

1.7

2.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

250

1817

1.39

5.72

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

3.46

5.71

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

2.47

5.67

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

202

2.18

5.56

1.5

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

289

1.98

5.56

2.0

1.6

0.6

3.3

u/field

2.99

212

(3045414) Leukocytes [Presence] in Urine

342

2622

1.32

5.53

1.8

—

(3016879) Cocaine [Presence] in Urine

397

3106

1.29

5.53

4.5

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

2.10

5.52

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

411

1.81

5.49

2.6

2.1

1.1

1.8

u/field

1.39

178

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

141

2.42

5.43

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.75

5.18

1.4

1.5

21.2

13.3

nmol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

295

2237

1.33

5.18

1.4

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.79

5.12

1.4

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

183

1287

1.43

5.10

1.8

1.6

9766.1

12140.7

e6/l

0.50

134

920

(40768441) Liver Pathology biopsy report

458

1.73

5.10

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.27

5.03

1.3

1.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

4.45

5.02

1.6

1.1

0.1

0.0

mg/l

0.70

(3024891) Influenza virus A+B Ag [Presence] in Specimen

249

1850

1.36

5.02

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

225

2.05

4.99

3.2

2.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

476

1.71

4.99

1.9

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

476

1.71

4.99

1.9

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

476

1.71

4.99

1.9

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

207

1495

1.39

4.97

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

419

3350

1.26

4.94

4.5

2.1

—

(3012898) Urea [Moles/volume] in Urine

3.03

4.93

1.8

1.7

160.8

170.8

mmol/l

0.15

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

222

1625

1.38

4.92

1.5

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.70

4.82

1.7

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

235

2.00

4.82

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

235

2.00

4.82

1.6

1.4

—

(3028300) Cannabinoids [Presence] in Urine

420

3374

1.26

4.77

4.6

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

150

1030

1.46

4.77

1.3

1.2

3.9

3.7

u/ml

0.04

345

(3027008) Opiates [Presence] in Urine

419

3366

1.26

4.76

4.4

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

341

4312

0.78

4.75

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.27

4.73

7.1

8.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

158

2.22

4.66

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.02

4.65

1.3

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1561

14087

1.14

4.64

1.7

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.84

4.64

11.6

12.1

4.9

5.8

mmol/l

1.04

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.14

4.61

2.0

3.0

—

(3032057) Clostridioides difficile [Presence] in Stool

103

2.53

4.61

1.8

2.0

—

(3021788) Differential panel - Synovial fluid

144

990

1.46

4.56

1.8

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

513

1.64

4.52

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

513

1.64

4.52

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

514

1.64

4.49

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

235

1.96

4.47

2.4

2.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

516

1.63

4.42

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

516

1.63

4.42

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

517

1.63

4.39

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.00

4.38

1.3

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.62

4.38

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

251

1.92

4.37

2.3

166.7

155.3

nmol/l

0.31

213

(3051651) Icteric interference index of Serum or Plasma

397

1.72

4.34

4.3

3.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

113

2.39

4.29

1.2

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

101

2.48

4.28

3.0

4.7

—

(3035880) pH of Pleural fluid

246

1.92

4.27

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

209

1554

1.35

4.25

1.5

1.4

263.5

251.8

u/ml

0.23

147

938

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

167

2.10

4.11

1.4

1.5

61.8

62.5

0.04

135

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.80

4.11

6.3

5.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

181

2.05

4.07

1.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

413

1.68

4.05

1.2

1.3

355.8

362.5

u/l

0.04

397

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

306

3840

0.79

4.04

1.4

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.34

4.03

1.1

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.50

4.03

1.3

1.7

98.2

134.7

ng/l

1.03

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.76

4.00

6.4

5.7

—

(3019174) dRVVT (LA screen)

2.93

4.00

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

362

1.72

3.99

5.8

6.8

—

(3020393) Adenovirus Ag [Presence] in Stool

156

2.12

3.97

2.3

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.93

3.97

1.0

1.1

77.6

223.2

pmol/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

608

5174

1.19

3.96

3.3

4.0

36.6

28.1

ug/l

0.20

480

4096

(40768446) Kidney Pathology biopsy report

289

1.80

3.95

2.4

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

312

1.77

3.91

1.9

2.8

64.7

51.6

umol/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

184

2.01

3.91

2.5

3.1

—

(4268621)

104

693

1.51

3.91

2.5

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

298

1.78

3.89

1.0

1.1

103.6

93.1

1.20

236

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

100

2.40

3.87

1.2

1.1

2.6

5.6

pmol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.56

3.87

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

404

3317

1.23

3.83

3.4

2.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

2.11

3.82

7.7

7.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

126

2.23

3.81

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

126

2.23

3.81

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

126

2.23

3.81

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

126

2.23

3.81

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

125

869

1.44

3.81

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

483

1.60

3.79

1.1

367.5

378.2

nmol/l

0.16

433

(3036782) Glucose [Moles/volume] in Pleural fluid

452

1.62

3.78

1.2

1.4

6.5

6.4

mmol/l

0.10

422

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.18

3.76

1.2

1.1

1.6

5.3

u/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.34

3.75

1.2

—

(3008898) HLA-B27 [Presence]

310

2481

1.26

3.71

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

260

2037

1.29

3.70

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

557

1.55

3.70

1.3

1.4

11.6

11.5

mmol/l

0.06

131

(3003338) MCHC [Mass/volume]

5330

54762

0.91

3.67

27.0

16.2

332.6

333.0

g/l

2.58

5297

54355

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

282

1.78

3.65

2.6

3.5

186.1

123.3

au/ml

0.39

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.63

3.65

1.1

—

(3036180) Methadone [Presence] in Urine

5.63

3.65

1.7

2.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

410

1.64

3.65

2.0

1.4

56.7

70.0

umol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

320

1.72

3.61

1.1

1433.9

1460.6

miu/ml

0.06

320

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

147

1066

1.39

3.56

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

611

1.51

3.55

1.4

1.5

30.1

33.5

g/l

1.45

556

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

157

2.04

3.54

1.7

1.4

111.5

101.3

1.36

149

(1002224) Polysomnography panel

339

2761

1.24

3.49

1.1

—

(1761868) Lipid panel - Serum or Plasma

2412

22615

1.10

3.42

3.2

2.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.76

3.41

1.3

1.1

—

(4024509)

505

1.55

3.39

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

249

1966

1.27

3.37

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

431

1.58

3.25

1.1

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

219

1.83

3.25

2.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

219

1.83

3.25

2.3

2.0

—

(4038314)

3.02

3.24

1.4

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

109

2.20

3.24

1.2

329.4

366.5

ug/l

0.03

(3023420) DNA double strand Ab [Units/volume] in Serum

674

1.46

3.22

1.8

1.5

32.8

23.8

iu/ml

—

(3004616) Nuclear Ab [Presence] in Serum

102

708

1.45

3.20

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

280

1.72

3.17

2.1

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

280

1.72

3.17

2.1

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

280

1.72

3.17

2.1

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

280

1.72

3.17

2.1

1.9

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

151

1.99

3.13

1.0

1.1

85.0

78.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

222

1.80

3.13

2.3

2.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.25

3.11

1.3

1.5

12.7

472506.8

nmol/l

1.08

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

958

8592

1.13

3.11

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

630

1.47

3.10

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

321

1.65

3.06

1.2

1.3

15.0

12.4

u/l

0.32

297

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.38

3.05

1.9

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.45

3.04

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

286

2331

1.24

2.98

1.6

1.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

10.00

2.97

1.0

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

5985

58581

1.10

2.97

22.1

13.8

39.7

40.1

2.40

4274

45201

(3047189) Immunofixation for 24 hour Urine

226

1.77

2.97

2.9

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

410

1.56

2.96

1.9

1.8

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.40

2.96

6.4

5.0

27.6

20.5

mg/l

1.78

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

547

1.49

2.95

1.1

1.3

189.3

205.6

titre

0.06

117

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.54

2.94

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

134

991

1.36

2.94

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

605

1.46

2.93

4.3

3.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

1.94

2.93

2.2

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

1.94

2.93

2.2

3.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

631

1.45

2.90

2.0

2.2

27.0

22.4

mg/l

0.24

170

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

184

1.85

2.90

2.3

2.6

28.4

28.8

umol/l

0.06

129

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

167

2158

0.77

2.89

1.4

1.5

—

(3042733) HLA Ab [Presence] in Serum

243

1.73

2.88

4.4

4.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

112

809

1.39

2.85

1.7

1.8

800.0

1277.8

titre

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

103

2.14

2.79

3.2

2.1

7.4

7.5

mmol/l

0.05

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

513

0.54

2.72

1.4

1.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

5.00

2.72

3.6

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

301

1.63

2.72

3.0

4.4

7.7

8.2

mg/l

0.17

241

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.36

2.71

6.8

5.2

—

(4015189)

118

2.04

2.70

2.5

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

420

1.53

2.69

1.4

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

2.69

2.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

139

1050

1.33

2.69

2.8

3.6

497.6

578.2

u/ml

0.09

119

966

(3032868) Hemoglobin electrophoresis panel in Blood

2.33

2.64

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

284

2347

1.22

2.63

1.3

202.2

229.4

miu/ml

0.58

104

1113

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

264

2167

1.23

2.62

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

571

1.44

2.60

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

137

1039

1.32

2.59

2.5

2.7

8.0

7.6

umol/l

0.10

109

783

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1042

9498

1.11

2.57

2.2

2.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

322

1.59

2.55

1.0

820.8

748.7

ng/l

0.61

215

(4034850)

228

1848

1.24

2.55

11.4

8.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

323

1.58

2.53

1.0

235.0

320.1

ng/l

2.74

222

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

157

1.85

2.51

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

324

1.58

2.50

1.0

33.4

44.5

ng/l

1.59

217

(3036670) Protein [Mass/volume] in Synovial fluid

144

1.88

2.45

1.3

1.2

35.4

39.5

g/l

0.68

(3043238) Trisomy 21 risk [Likelihood] in Fetus

126

1648

0.76

2.44

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.94

2.40

4.0

4.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.29

2.40

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.17

2.40

1.2

0.0

u/ml

0.84

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

138

1.89

2.40

1.6

1.3

44.7

35.0

0.70

(3000492) Spirometry study

682

6093

1.13

2.39

1.5

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

167

1.80

2.39

4.1

2.0

0.8

1.6

mmol/l

1.76

128

(3000285) Sodium [Moles/volume] in Blood

2.34

2.38

1.7

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

717

1.37

2.37

1.2

1.1

98.1

95.6

0.42

674

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

359

3065

1.18

2.37

2.8

3.2

108.3

49.6

u/ml

0.31

342

2959

(3013166) Neutrophils/100 leukocytes in Synovial fluid

161

1.80

2.34

1.8

1.3

58.1

52.1

0.32

133

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

443

1.47

2.33

1.4

1.2

25.4

43.8

u/ml

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.31

2.30

1.4

1.6

9.4

7.2

—

(3013466) aPTT in Blood by Coagulation assay

2.86

2.30

1.1

32.3

36.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

207

2528

0.81

2.28

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

158

1987

0.79

2.27

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

203

0.39

2.27

1.8

3.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.62

2.27

1.2

1.1

190.5

103.5

nmol/24h

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

158

1985

0.79

2.26

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.02

2.25

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.89

2.25

1.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

3.89

2.25

1.4

1.1

239.2

65.0

mg/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

113

1.95

2.24

3.4

2.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

556

1.41

2.22

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

158

1981

0.79

2.22

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

442

3857

1.15

2.22

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.09

2.22

1.7

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

124

1600

0.77

2.21

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

100

2.00

2.19

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

121

1.90

2.19

2.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.78

2.19

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

460

4030

1.15

2.19

1.2

—

(40757373) Influenza virus identified in Isolate

114

1.93

2.19

1.8

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

158

1977

0.79

2.19

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

492

1.43

2.17

1.7

1.4

12169.2

74369.0

e6/l

1.83

344

(3005033) Fetal Nuchal fold Thickness US

124

1594

0.77

2.15

1.4

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

101

1.98

2.14

2.1

3.8

4.0

3.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.00

2.14

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

131

1018

1.29

2.14

1.8

2.1

1.2

2.4

titre

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.36

2.11

1.2

1.3

—

(40768806) Pleura Pathology biopsy report

487

1.42

2.10

1.4

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.70

2.10

1.2

1.3

—

(3025315) Body weight

2.45

2.10

4.9

3.7

—

(3011648) Oxygen content in Venous blood

529

1.40

2.09

9.4

5.8

11.5

11.4

0.11

529

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

102

1.96

2.09

1.1

1.3

0.8

136.1

mg/l

1.20

(3017315) Amylase [Enzymatic activity/volume] in Urine

300

1.54

2.07

1.9

1.3

204.1

361.1

u/l

1.63

275

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

3.50

2.05

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.50

2.05

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

219

1815

1.21

2.05

3.0

3.4

132.6

3020.0

u/ml

1.17

178

1548

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

358

1.48

2.03

1.6

1.4

23.5

19.8

u/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.11

2.01

1.2

1.3

0.6

1.5

mmol/l

—

(3032641) Amino acids panel - Urine

3.08

2.01

1.4

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.81

1.99

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.98

1.94

1.2

1.3

43.2

58.8

ng/l

0.20

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

157

1265

1.25

1.94

1.6

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

120

1.83

1.91

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

203

1.63

1.91

2.2

1.5

—

(21494434) Karyotype in Bone marrow

472

1.40

1.89

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.96

1.89

1.1

1.2

1.3

1.7

mmol/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.86

1.86

3.5

4.2

4.5

mmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

114

1448

0.78

1.85

1.3

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

442

1.41

1.82

2.1

2.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

130

1035

1.26

1.80

1.1

4.0

3.9

u/ml

0.03

488

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.04

1.79

5.6

5.4

460.9

432.5

umol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.04

1.79

6.4

3.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

319

1.48

1.79

1.3

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

319

1.48

1.79

1.3

2.1

—

(3005570) Glucose [Moles/volume] in Urine

539

1.36

1.76

2.2

1.9

—

1.1

—

(3049233) Organic acids panel - Urine

2.44

1.75

1.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.33

1.74

1.3

1.2

1.7

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

400

3535

1.14

1.74

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

155

1.68

1.71

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

186

1.61

1.71

1.8

1.5

9.7

8.6

ug/l

0.59

186

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

910

0.74

1.66

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

212

1.56

1.64

1.4

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

228

1.54

1.64

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

153

1847

0.82

1.60

1.4

1.6

—

(3020650) Glucose [Presence] in Urine

174

1.61

1.60

1.8

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.87

1.60

1.2

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.59

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.91

1.59

2.9

2.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

321

1.43

1.56

1.1

1.2

13.8

u/ml

0.81

215

(3005082) Progesterone [Moles/volume] in Serum or Plasma

414

1.38

1.55

1.3

1.4

35.8

31.6

nmol/l

0.32

363

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

107

1.78

1.54

1.5

1.4

14.0

24.7

1.42

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.59

1.51

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

163

1.60

1.45

1.0

1.1

—

208.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

310

1.42

1.44

1.5

1.3

60.0

483.5

titre

—

(44813793)

515

1.32

1.44

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.12

1.43

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.12

1.43

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.03

1.43

1.2

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

133

1.65

1.41

2.9

3.6

45.7

98.3

u/l

0.73

(3015183) Erythrocyte sedimentation rate

354

1.39

1.40

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

527

1.31

1.39

1.5

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.08

1.38

1.0

1.2

4.0

5.8

mmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

1.94

1.37

1.5

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.19

1.36

3.1

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

310

0.61

1.35

1.6

1.3

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.34

0.0

1.3

—

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

464

1.32

1.28

1.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

301

1.40

1.28

1.5

1.3

66.0

68.5

titre

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.08

1.27

1.1

9.3

15.2

u/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

767

1.24

1.26

1.1

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.22

1.24

1.0

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

220

1.46

1.22

2.8

2.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.16

1.21

1.8

1.3

—

(3022621) pH of Urine by Test strip

414

3765

1.10

1.18

3.7

2.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.31

1.18

3.7

10.2

—

(40768795) Lymph node Pathology biopsy report

533

1.28

1.17

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.16

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

420

1.31

1.15

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.50

1.15

10.0

6.1

—

(4146454)

518

1.28

1.13

2.6

2.7

—

(4094501)

176

1523

1.16

1.13

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

596

5527

1.08

1.12

2.0

—

(3024263) Appearance of Synovial fluid

292

1.37

1.12

1.9

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

284

1.37

1.11

5.3

5.0

68.7

68.1

mg/l

0.02

219

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

752

7047

1.07

1.09

1.7

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.95

1.08

1.1

1.6

387.3

340.9

umol/24h

—

(3043410) Blood group antigens tested for on Red Blood Cells

160

1.50

1.08

1.9

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.82

1.08

1.0

1.1

—

(3048879) Bone marrow aspiration report

136

1.54

1.08

1.4

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

541

1.26

1.06

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

559

1.25

1.06

1.5

7460.7

2573.7

e6/l

0.44

403

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

245

1.39

1.04

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.27

1.03

3.8

5.4

—

(3014051) Protein [Presence] in Urine by Test strip

154

1331

1.16

1.03

2.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.06

1.02

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.91

1.02

1.1

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.89

1.01

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.00

1.00

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

582

1.24

1.00

1.1

1.2

6.4

2.9

u/ml

0.61

238

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.62

0.99

2.6

2.5

—

(44806071)

1.67

0.97

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.97

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.94

0.97

1.0

2.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.94

0.97

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

140

1211

1.16

0.95

1.1

13.8

12.1

au/ml

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.76

0.94

8.6

4.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

126

1082

1.17

0.94

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.89

0.94

1.4

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

813

7687

1.06

0.93

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

817

1.19

0.91

2.3

2.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.07

0.89

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.90

0.88

1.1

1.0

—

17.1

iu/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

289

0.69

0.88

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

359

1.28

0.87

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.67

0.84

1.0

1.1

—

(3024932) HLA-DR beta [Type]

247

1.34

0.84

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

126

1094

1.15

0.84

1.6

—

(3012441) Differential panel - Pleural fluid

478

1.24

0.84

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

274

1.31

0.83

1.3

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

140

0.57

0.82

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

473

4417

1.07

0.81

1.8

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

141

1239

1.14

0.80

4.2

3.4

25.8

25.9

mg/l

0.01

761

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.70

0.80

3.8

4.9

—

(3003694) ABO and Rh group [Type] in Blood

1855

17988

1.04

0.79

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.72

0.79

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

348

3759

0.92

0.79

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.82

0.79

1.5

1.8

—

(3024471) HLA-A [Type]

251

1.32

0.77

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

148

1668

0.88

0.77

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

124

0.56

0.77

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.77

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.76

0.76

1.5

1.4

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.00

0.72

1.0

19.7

21.4

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.00

0.72

1.0

11.9

8.3

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.00

0.72

1.0

36.3

36.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

1.50

0.72

1.2

—

(3013762) Body weight Measured

1.92

0.70

1.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.71

0.69

4.3

2.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.85

0.68

1.0

1.1

—

(40768793) Breast Pathology biopsy report

115

1303

0.88

0.68

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

1.56

0.68

3.8

6.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1027

10666

0.96

0.68

1.5

—

(40758292) HTLV I+II Ab panel - Serum

110

1.45

0.68

1.3

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

595

0.82

0.67

1.3

1.6

7.8

7.6

mmol/l

0.28

365

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

119

1.43

0.66

1.2

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

303

0.76

0.63

3.9

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

497

1.19

0.62

3.3

3.0

61.3

51.5

mg/l

0.12

371

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

151

1364

1.11

0.60

1.3

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.60

0.0

1.2

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

4.2

—

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

139

1.37

0.60

1.3

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.58

0.0

1.3

—

(3025577) Chromium [Mass/volume] in Blood

282

1.24

0.57

2.2

2.0

2.9

2.4

ug/l

0.40

239

(3028308) Erythrocytes [#/volume] in Pleural fluid

502

1.18

0.57

1.5

1.4

113344.4

65251.2

e6/l

0.29

294

(3042951) Complement C1q Ab [Units/volume] in Serum

1.67

0.56

1.0

1.1

—

23.6

—

(3022670) pH of Venous cord blood

1.62

0.55

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.44

0.55

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

814

1.13

0.54

3.2

3.1

0.8

nmol/l

0.33

616

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.54

0.53

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

122

1100

1.11

0.52

1.2

1.1

—

(3034426) Prothrombin time (PT)

242

1.24

0.50

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1103

0.90

0.49

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

454

1.17

0.49

3.2

2.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

101

1.39

0.49

4.0

2.8

1168.8

1916.2

u/l

0.27

(3025130) Human papilloma virus identified in Specimen

902

0.89

0.49

1.7

1.8

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.55

0.48

1.1

—

4.3

—

(4281824)

572

0.86

0.48

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

113

1021

1.11

0.48

1.7

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

911

0.89

0.48

4.3

3.7

73.5

31.7

u/ml

0.55

881

(3022475) Manganese [Moles/volume] in Blood

1.52

0.48

1.1

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

290

1.21

0.47

1.1

5.6

7.9

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

173

1.27

0.46

2.0

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

120

0.67

0.45

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.43

0.45

5.6

10.3

—

(3017509) Phencyclidine [Presence] in Urine

1.40

0.44

2.3

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

174

0.75

0.43

2.2

1.9

6705.9

16104.4

e6/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

294

1.19

0.42

1.4

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

286

1.19

0.41

2.3

2.0

4.4

3.0

ug/l

0.44

257

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.41

1.1

—

(3045788) Cell count panel - Pleural fluid

454

1.15

0.40

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.39

0.40

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

784

8077

0.97

0.40

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

234

2204

1.06

0.40

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

141

1.28

0.40

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

141

1.28

0.40

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

141

1.28

0.40

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

160

0.75

0.39

2.2

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.43

0.39

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.39

0.0

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

190

1779

1.07

0.39

1.2

2.6

1.9

u/ml

0.21

838

(44806420)

124

1.29

0.38

2.3

2.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.34

0.38

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

419

0.86

0.37

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

116

0.69

0.36

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

173

1621

1.07

0.36

1.1

3.8

6.1

u/ml

1.35

946

(3009871) Measles virus Ab [Titer] in Serum

235

1.19

0.35

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

149

1390

1.07

0.35

1.4

1.5

88.7

144.5

pmol/l

1.69

144

1357

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

262

2489

1.05

0.35

1.8

1.7

3.9

3.7

mg/l

0.21

192

1741

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

0.74

0.35

1.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.39

0.35

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

265

0.83

0.34

2.2

1.8

—

(40768800) Prostate Pathology biopsy report

856

0.91

0.34

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.33

0.33

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.30

0.33

12.5

9.7

533.5

128.1

e6/l

—

(3001729) Color of Synovial fluid

1.28

0.32

2.8

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

120

1.25

0.30

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.31

0.29

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.27

1.3

1.1

—

(4133840)

172

0.81

0.27

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

258

2475

1.04

0.26

1.8

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

216

2257

0.96

0.26

1.4

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.30

0.26

1.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

397

1.11

0.24

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

145

1524

0.95

0.23

1.1

0.5

2.6

u/ml

6.05

408

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

380

0.89

0.23

1.2

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

567

0.92

0.23

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

574

1.08

0.21

1.1

1.2

2.0

8.6

u/ml

1.06

208

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.5

—

2185.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

104

0.77

0.21

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

163

1564

1.04

0.19

1.1

1.3

1.1

u/ml

0.15

795

(3006598) pH of Arterial cord blood

122

0.82

0.19

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

117

1114

1.05

0.19

1.1

4.5

5.3

u/ml

0.21

491

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

241

1.12

0.19

2.5

2.4

9.1

9.7

mg/l

0.26

206

(3033799) Differential panel - Peritoneal fluid

164

0.85

0.18

1.9

2.0

—

(3020491) Glucose [Moles/volume] in Blood

463

1.08

0.18

1.5

1.8

7.0

6.4

mmol/l

0.82

335

(40761995) Spermatozoa Progressive [#/volume] in Semen

204

1.13

0.17

3.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

204

1.13

0.17

5.9

5.8

—

(3014891) Appearance of Pleural fluid

1.15

0.17

2.1

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

141

0.85

0.16

1.9

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

158

1.14

0.16

11.5

6.3

—

(3002619) Bacteria identified in Specimen by Culture

129

0.85

0.14

1.4

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.78

0.14

13.3

7.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

999

0.96

0.13

1.0

1.1

0.1

0.4

u/ml

2.24

279

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

114

1098

1.04

0.13

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

132

1.14

0.13

1.2

1.5

11.5

12.0

g/l

—

100

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

239

1.09

0.12

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

130

1259

1.03

0.12

1.1

—

(40765096) Chromosome analysis panel by Banding

168

0.89

0.11

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.16

0.11

1.5

4.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

130

1260

1.03

0.11

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

504

1.05

0.10

1.1

0.4

1.5

u/ml

—

(3037556) Urate [Mass/volume] in Serum or Plasma

146

0.89

0.10

1.6

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

144

1.11

0.10

10.6

6.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

300

1.07

0.09

6.4

8243.1

9869.5

u/ml

—

(4212803)

1.11

0.09

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

278

0.93

0.09

1.3

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.11

0.09

1.0

1.1

11.4

9.8

mg/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

537

1.04

0.08

1.1

6.3

8.9

iu/ml

0.67

130

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.03

0.08

2.0

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.03

0.07

1.6

2.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.84

0.07

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

285

1.05

0.06

4.0

3.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

507

0.97

0.06

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

284

0.95

0.06

2.0

73.8

210.8

ug/min

0.87

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

324

0.96

0.05

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

122

1201

1.02

0.04

1.1

1.7

4.5

u/ml

4.07

512

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

259

1.04

0.04

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

898

0.99

0.01

1.2

1.4

7.1

mmol/l

0.02

656

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

267

0.97

0.01

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

213

1.03

0.01

16.9

11.2

—

(4211845)

313

1.02

0.01

3.8

3.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

102

0.98

0.00

1.6

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

244

0.98

0.00

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

115

1.04

0.00

1.7

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

175

0.97

0.00

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.9

—

11.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1294.3

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.95

0.00

19.4

9.2

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.01

0.00

1.9

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.8

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_PCOS_BROAD_EXCLUSIONS – Exclusions for E4_PCOS_BROAD

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exclusions for E4_PCOS_BROAD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exclusions for E4_PCOS_BROAD (E4_PCOS_BROAD_EXCLUSIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints